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Fusarium fungal species are major contaminants of maize and produce a highly toxic mycotoxin 
– Fumonisin B1 (FB1). Fumonisin B1 is the causative agent for many incidents of animal-related 
mycotoxicoses and has been implicated in human and animal cancer. Oxidative stress and 
mitochondrial integrity is of current research interest with regards to tumorigenesis. The aim of 
this study was to investigate the effect of FB1 on oxidative stress-related survival responses in 
HepG2 cells. 
Intracellular ROS levels (H2DCF-DA assay), and markers of oxidative stress: lipid peroxidation 
(TBARS) and protein oxidation (protein carbonyl assay) were quantified using 
spectrophotometry. Luminometric quantification of GSH and CAT activity was determined as a 
measure of intracellular antioxidant potential. The relative expression of oxidative stress and 
mitochondrial stress response proteins (Nrf2, pNrf2, SOD2, CAT, Sirt 3 and Lon-P1) were 
quantified by western blotting, while gene expression levels of SOD2, CAT, GPx, Tfam and 
OGG1 were assessed using qPCR. The fluorometric, JC-1 assay was used to determine 
mitochondrial polarisation (∆ᴪm). Lastly, the expression of cancer related proteins (c-Myc, p53 
and p-ser20-p53) were also determined using qPCR and western blotting. 
FB1 significantly elevated intracellular ROS (p≤0.001), and induced lipid peroxidation (p<0.05) 
and protein carbonylation (p≤ 0.0001), with a corresponding increase in GSH levels (p<0.05).  A 
significant increase in pNrf2, SOD2, SOD2, CAT (p<0.05), CAT (p≤ 0.01), GPx (p≤ 0.001) 
expression was observed, however total Nrf2 (p>0.05), OGG1expression and CAT activity (p≤ 
0.01) was reduced. There was also a minor reduction in the ∆mᴪ of HepG2 cells (p<0.05), 
however the expression of Tfam (p<0.05), Sirt 3 and Lon-P1 (p≤ 0.001) were upregulated. 
Although, transcript levels of the c-Myc were increased (p≤ 0.001); protein expression was 
reduced (p>0.05). The protein expression of p-ser20-p53 (p<0.0001) was elevated, however 
expression of total p53 was decreased (p>0.05).  
Fumonisin B1 induced oxidative stress in HepG2 cells. Although cell survival responses were 
initiated, the anti-oxidant capacity was not enough to deal with the excessive ROS. Furthermore, 
mitochondrial survival responses initiated by the cell may possibly contribute to pro-survival 




CHAPTER 1 – INTRODUCTION 
 
Maize is a staple component in the diet of millions worldwide (Ranum, Peña‐Rosas et al. 2014). 
This cereal crop, however, is under constant threat from pests, parasites and fungi. Fungal 
contamination is especially dangerous as secondary metabolites (mycotoxins) have demonstrated 
toxic effects in humans and animals. The Fusarium fungal genus is a major mycotoxin producer 
and maize contaminant (Fandohan, Hell et al. 2003). Fusarium verticillioides and F. proliferatum 
are commonly associated with maize contamination and  are the most abundant producers of the 
Fumonisin family of mycotoxins (Rheeder, Marasas et al. 2002). 
The most toxicologically significant member of the Fumonisin family is Fumonisin B1 (FB1). The 
structure of FB1 bares close resemblance to sphingolipid precursors and therefore exerts its 
toxicity by inhibiting the de novo synthesis of sphingolipids. This inhibitory action interferes with 
signal transduction, cell cycle regulation and the functioning of lipid containing molecules such 
as cell membranes (Desai, Sullards et al. 2002, Voss, Howard et al. 2002). 
Owing to FB1’s resistance to food processing and storage conditions, it poses a significant hazard 
to both animal and human health. It has been linked to equine leukoencephalomalacia (ELEM); 
porcine pulmonary oedema (PPO) and the development of carcinomas and hepatotoxicity in 
rodents (Šegvić and Pepeljnjak 2001). Humans are constantly exposed to low doses of FB1.  
Despite the tolerable daily intake of FB1 being 2µg; daily intake can range from 12 to 
140µg/person, peaking at 2 500µg/person in regions where maize is a staple dietary component 
(WHO 2012). Epidemiological studies have shown a correlation between regions with a high 
maize consumption and a high occurrence of oesophageal and hepatocellular carcinomas 
(Stockmann-Juvala and Savolainen 2008, Persson, Sewram et al. 2012).  Therefore FB1 has been 
classified as a class 2B carcinogen by the International Agency for Research on Cancer (IARC) 
(Stockmann-Juvala and Savolainen 2008). 
Although a major portion of FB1 is distributed to the liver, few studies have investigated the 
effects of FB1 on the development of hepatotoxicity and liver cancer. While it is known that FB1 
is involved in tumorigenesis, the underlying mechanism of its cancer promoting properties are 
not well established.  Recently, chromatin instability through FB1 induced hypomethylation of 
global DNA has been implicated as an alternative mechanism of FB1-mediated tumorigenesis 
(Chuturgoon, Phulukdaree et al. 2014).  
Fumonisin B1-induced oxidative stress has received close review in recent years, however it has 
not been investigated as a factor that could contribute to FB1-mediated tumorigenesis.  Oxidative 
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stress occurs when there is a rise in the production of reactive oxygen species (ROS) and/or 
reduction in the anti-oxidant (AO) capacity of cells (Birben, Sahiner et al. 2012).  Mitochondria 
house the electron transport chain (ETC), which leaks unpaired electrons (e-) into the 
mitochondrial matrix. These e- react with molecular oxygen (O2) to form ROS (Bratic, Larsson et 
al.). FB1 is able to disrupt mitochondrial respiration by inhibiting complex I of the ETC, 
accelerating the generation of ROS by the mitochondria (Domijan and Abramov 2011).  
The first line of defence against oxidative stress in cells is the induction of endogenous AO 
proteins, which scavenge ROS and dampen oxidative damage to macromolecules. Nuclear-factor-
erythroid 2 p45-related factor 2 (Nrf2) is a transcription factor that regulates the Antioxidant 
Response Element (ARE), responsible for the expression of AO genes such as glutathione 
peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) (Nguyen, Nioi et al. 2009).  
Considering that dysregulation of the ETC by FB1 is involved in the generation of excess ROS, 
mitochondrial health may be affected (Chen, Vazquez et al. 2003). Mitochondrial transcription 
factor A (Tfam), silent information regulator 3 (Sirt 3) and Lon-protease 1 (Lon-P1) contribute to 
mitochondrial well-being under oxidative stress conditions. Sirtuin 3 activates mitochondrial AO 
such as Super oxide dismutase 2 (SOD2), increasing the detoxification capacity of the 
mitochondria (Ansari, Rahman et al. 2017). Lon-protease 1 and Tfam do not have any direct AO 
capabilities; Tfam protects mitochondrial DNA (mtDNA) against oxidative damage, whereas 
Lon-P1 is involved in degrading oxidised proteins within the mitochondria (Bezawork-Geleta, 
Brodie et al. 2015, Oka, Leon et al. 2016).  
Functional mitochondria are essential for the survival of cancer cells. Although high levels of 
ROS within the mitochondrial matrix cause mutations to mtDNA, these mutation do not usually 
disrupt the functioning of mitochondria but rather alter the bio-energetic and bio-synthetic states 
to ensure that the energy and growth requirements of cancer cells are met (Wallace 2012). While 
high ROS levels are beneficial to cancer cells they must be maintained at certain levels to ensure 
that cell death pathways are not initiated (Liou and Storz 2010). Furthermore a close relationship 
exists between ROS, and tumour suppressor genes (p53) and oncogenes (c-Myc and KRAS). 
Similarly, Nrf2 also has tumour suppressing and oncogenic properties. Nrf2 inhibits the early 
stages of carcinogenesis, however prolonged activation of Nrf2 promotes the survival of cancer 
cells (Sporn and Liby 2012). 
The role of oxidative stress and the activation of Nrf2 in relation to tumorigenesis is of current 
research interest. While it is known that FB1 is linked to tumorigenesis, the underlying mechanism 
of its cancer promoting properties are not well established. Therefore this study focused on the 
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effect of FB1 on oxidative stress-related survival responses in HepG2 cells following 24 hours 
exposure – as an alternative mechanism of FB1 mediated cancer progression. 
1.1.  Aim: 
To investigate the effect of FB1 on oxidative stress-related survival responses in HepG2 cells. 
1.2. Hypothesis: 
Excess ROS generated by FB1 exposure would trigger oxidative stress-related responses and alter 
the expression of cancer-related proteins. 
1.3.  Objectives: 
 To determine the extent of ROS generation and oxidative damage by FB1 in HepG2 
cells. 
 To determine the Nrf2-mediated AO response and AO capacity of HepG2 cells when 
exposed to FB1. 
 To determine the effects of FB1 on mitochondrial stress responses. 
















CHAPTER 2 – LITERATURE REVIEW 
 
2.1. The Fumonisins 
Fungal secondary metabolism produces an assortment of diverse molecules which exhibit potent; 
sometimes toxic, biological activities. The adverse health outcomes in animals and humans 
associated with these secondary metabolites, known as mycotoxins, are often overlooked (Bennett 
and Klich 2003).  
Humans and animals are frequently exposed to mycotoxins through the consumption of mouldy 
agricultural commodities such as wheat, rice, tea, sorghum, fruit, vegetables and most 
importantly, maize (Yazar and Omurtag 2008). Maize forms a vital part of the African staple diet 
due to its high yields, adaptability to different climates and versatile uses and storage capabilities 
(Fandohan, Hell et al. 2003).   
Unfortunately, more than 60% of all maize and maize based products are contaminated by the 
family of mycotoxins known as Fumonisins. In addition to maize, the occurrence of Fumonisins 
have been reported in rice, sorghum, beans and wheat (Yazar and Omurtag 2008). Fumonisins 
were first isolated in 1988 during an Equine leukoencephalomalacia (ELEM) outbreak in South 
Africa (Marasas 2001). They are produced by the fungal genus Fusarium and the highest 
producers of fumonisins include F. verticillioides, F. proliliferatum and F. anthophilum. 
Presently, there are 28 fumonisin analogues that are classified into 4 groups: A, B, C and P. 
Fumonisin B1 (FB1), Fumonisin B2 (FB2) and Fumonisin B3 (FB3) are the principal fumonisins 
found in maize, with FB1 being the most predominant and toxic (Yazar and Omurtag 2008).   
2.1.1 Fumonisin B1 
The first fumonisin discovered was FB1 and it remains the most toxicologically significant. It has 
been reported as the causative agent for many incidents of animal related mycotoxicoses and has 
been implicated in both human and animal cancer (EC 2002). 
Maize contaminated with FB1 is usually symptomless; thus infected maize easily enters the food 
chain. It is a relatively stable compound that is temperature resistant, and can therefore persist 
during food processing. It is poorly absorbed when consumed and is rapidly eliminated from the 
body. A pool of FB1, however, does persist in the liver and kidney, where it exerts most of its 




2.1.1.1. Chemical Structure 
The structure of FB1 is represented as a diester of propane-1,2,3-tricarboxylic acid and 2-amino-
12,16-dimethyl-14,15-dihydroxyecosane in which the hydroxyl (OH) groups of carbon 14 and 15 
are esterified to tricarboxylic acid (TCA). Unlike most mycotoxins which consist of cyclic 
structures, FB1  has a long polyketide-derived backbone to which TCA, methyl, OH and amino 
groups are attached (Figure 2.1) (Stockmann-Juvala and Savolainen 2008). It is a polar molecule 
and is therefore soluble in water and other aqueous solvents (WHO 2001).  
The primary amino group in FB1 closely resembles the sphingolipid precursors, sphinganine and 
sphingosine. This characteristic allows FB1 to disrupt sphingolipid metabolism. Studies have also 
shown that the acetylation of the amino group in FB1 inhibits its toxicity and ability to disrupt 
sphingolipid metabolism (Stockmann-Juvala and Savolainen 2008). 
 
Figure 2.1: Structure of FB1 (Stockmann-Juvala and Savolainen 2008 – modified by author). 
 
2.1.1.2. Mechanism of action 
The remarkable structural similarity between FB1 and sphingoid bases suggests FB1 exerts its 
toxicity through the disruption of sphingolipid metabolism (Heidtmann-Bemvenuti, Mendes et al. 
2011). Sphingolipids are abundant in all eukaryotic cells as they form major components of 
membranes, lipoproteins and other lipid rich structures. They are critical in maintaining the 
structure of membranes and modulating the activity of receptors (Merrill, Schmelz et al. 1997). 
Sphingolipids and its metabolites also mediate vital signalling pathways such as differentiation, 
cell cycle progression, proliferation, and apoptosis (Merrill, Sullards et al. 2001). 
Synthesis of sphingolipids occurs de novo in the endoplasmic reticulum. Serine 
palmitoyltransferase initiates sphingolipid synthesis by catalysing the condensation of serine and 
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palmitoyl Coenzyme A (palmitoyl CoA) to form 3-ketosphinganine. 3-ketosphinganine is 
reduced to sphinganine in a nicotinamide adenine dinucleotide phosphate (NADPH)-dependant 
manner (Futerman and Riezman 2005). Sphinganine can either undergo phosphorylation to form 
sphinganine-1-phosphate or acylation to form dihydroceramide by ceramide synthase. 
Dihydroceramide is desaturated to ceramide, which can then be converted to complex 
sphingolipids such as glycosphingolipids and sphingomyelin. As seen in figure 2.2, ceramide 
synthase is also responsible for reacylation of sphingosine to ceramide via the sphingolipid 
degradation pathway (Šegvić and Pepeljnjak 2001).  
Both FB1 and sphingoid bases contain an aminopentol backbone. Due to this similarity, ceramide 
synthase recognizes FB1 as a substrate and allows it to compete with sphingoid bases for the same 
binding site in ceramide synthase. The tricarboxylic group of FB1 also obstructs the fatty acyl-
CoA binding site of ceramide synthase, thus inhibiting ceramide synthase (Wang, Norred et al. 
1991). The inhibition of ceramide synthase impedes ceramide biosynthesis; thus obstructing the 
formation of complex sphingolipids; increasing sphingosine and sphinganine accumulation, and 
reducing reacylation of sphingosine (Figure 2.2). At high concentrations sphingoid bases become 
cytotoxic and can trigger cell injury and membrane degradation (Merrill, Sullards et al. 2001). 
 




A) Toxicity in animals  
The pathogenic effects of FB1 has been well established in many farm and laboratory animals. 
Livestock are most risk as their feed are generally contaminated by FB1 and other mycotoxins. 
The liver and kidney are major targets of FB1 in almost all animal species and, depending on the 
animal, may exhibit additional effects (WHO 2001). 
During the twentieth century, there were several outbreaks of the fatal ELEM across a number of 
countries such as the Unites States and South Africa (Stockmann-Juvala and Savolainen 2008). 
This neurotoxic disease was associated with the consumption of mouldy corn contaminated with 
FB1. It occurs only in equids and is characterised by the presence of liquefactive necrotic lesions 
in the subcortical white matter of the cerebrum. Necrotic lesions may also develop in the brain 
stem, cerebellum and spinal cord (Šegvić and Pepeljnjak 2001). Affected equids present with 
depression, ataxia and convulsions; and death can occur within several hours after the first 
symptoms occur (EC 2002). Other organs that are affected include: the liver, which shows signs 
of swelling and irregular white nodules; and the kidney, where nephrosis and nephropathy occur 
(Šegvić and Pepeljnjak 2001). 
In swine, the most relevant toxicosis of FB1 is PPO and hydrothorax (Šegvić and Pepeljnjak 
2001). Swine develop PPO within a week of consuming FB1 contaminated feed. Common 
symptoms include dyspnoea, cyanosis, respiratory distress, decreased heart rate and inactivity just 
before death (Haschek, Gumprecht et al. 2001, EC 2002). Alongside PPO, swine experience 
lesions and necrosis in the liver and kidney and the concentration of sphingoid bases are elevated 
in the lung, liver and kidney (Šegvić and Pepeljnjak 2001). 
Several subacute and chronic studies with FB1 have been performed in rat and mouse models. 
Nephrotoxicity and hepatotoxicity were observed in rats but only hepatotoxicity was observed in 
mice. FB1-induced hepatotoxicity consisted of necrosis accompanied by changes in the lipid 
ratios, distortion of liver lobules, and the development of hyperplastic nodules. Nephrotoxicity 
was characterised by hyperplasia, necrosis of tubules, fatty changes and pyknosis (EC 2002).  
The potential of carcinogenicity of FB1 has been studied in primates, rats and mice. In some 
species of male rats, cholangiocarcinomas, hepatocellular carcinomas and renal tubular tumours 
have been observed, while female rats did not show any signs of carcinogenicity. Fumonisin B1 
also induced hepatocellular carcinomas and adenomas in male mice; while female mice were not 
affected (Stockmann-Juvala and Savolainen 2008). There is presently no evidence that suggests 
FB1 induces carcinogenicity in primates (Šegvić and Pepeljnjak 2001). 
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B) Toxicity in humans 
Humans are constantly exposed to low doses of FB1.  Despite the tolerable daily intake of FB1 
being 2µg (WHO 2002),  consumption per day can range from 12 to 140µg/person, and peaks at 
2 500µg/person in regions where maize is a  staple (WHO 2012). Epidemiological studies have 
shown a correlation between regions with a high maize consumption and a high occurrence of 
oesophageal and hepatocellular carcinomas in parts of South Africa, China, Iran, Italy, United 
States, Zimbabwe, Kenya and Brazil (Sun, Wang et al. 2007, Stockmann-Juvala and Savolainen 
2008, Ncube, Bradley C. Flett et al. 2011, Alizadeh, Rohandel et al. 2012, Persson, Sewram et al. 
2012). The International Agency for Research on Cancer (IARC) has therefore classified FB1 as 
a class 2B carcinogen; a class of molecules that are carcinogenic to animals and possibly humans 
(Stockmann-Juvala and Savolainen 2008).  
Consumption of FB1 contaminated maize by pregnant woman, is involved in development of 
neuronal tube defects (NTD) in their offspring. This embryonic defect results from malformation 
of neuronal tubes in the brain and spinal cord (WHO 2001). Folate deficiency is a major cause of 
NTD. Alterations in sphingolipid content of cell membranes, distorts receptors such as the folate 
receptor and prevents the uptake of folate which increases the risk of NTD (Sadler, Merrill et al. 
2002). 
Consumption of FB1 can also lead to acute mycotoxicosis. This was evidenced by an outbreak of 
diarrhoea and abdominal pain in 27 villages in India after residents consumed rain damaged 
mouldy maize and sorghum that contained high levels of FB1 when analysed (Stockmann-Juvala 
and Savolainen 2008). 
 
2.2 Oxidative stress  
Oxygen, the most essential element for living organisms, is required for the generation of 
adenosine triphosphate (ATP). This process results in the production ROS, which can be both 
beneficial and harmful to cells. Excess ROS leads to the disruption of redox signalling and 
damage to cellular structures. In order to neutralize the effects of excess ROS, cells employ AO 
to scavenge ROS and prevent/repair ROS induced damage (Kabel 2014). Oxidative stress is a 
condition whereby the balance between ROS and AO is shifted towards ROS. Oxidative damage 
has been implicated with a myriad of pathological conditions such as cancer, neurodegenerative 
disorders, cardiovascular diseases, auto-immune disorders and contributes to biological aging 




2.2.1 Reactive oxygen species: The good, the bad and the ugly 
In vertebrates, the evolution of aerobic metabolic processes such as respiration have unavoidably 
led to the production of ROS. Molecular oxygen (O2) has two unpaired e-, which makes it prone 
to e- transfer reactions. When O2 gains an e- it forms the reactive anion, superoxide (O2•-) (Figure 
2.4); which can be sequentially reduced to hydrogen peroxide (H2O2) and hydroxyl radicals (OH•) 
(Apel and Hirt 2004). Thus, ROS is the collective term used to describe unstable molecules that 
are primarily derived from O2 (Gorrini, Harris et al. 2013). The most abundant ROS – which 
includes the radicals: O2•-, OH•, peroxyls (RO2•), hydroperoxyl (HO2•) and non-radical oxidizing 
agents such as H2O2 and ozone  (O3) – are listed in figure 2.3 (Bayir 2005).  
 
Figure 2.3: The most physiologically abundant ROS (prepared by author). 
 
Reactive oxygen species are double edged swords. At low concentrations ROS play an important 
part in mediating many metabolic and cellular processes such as gene expression, phagocytosis, 
immunity, proliferation, cell growth, cell death and is involved in maintaining cellular 
homeostasis in the body (Noori 2012). Conversely, any alterations in homeostasis that results in 
enhanced ROS production, can damage cell membranes via lipid peroxidation, form lethal DNA 
lesions and enhances protein modifications and degradation. Many more radicals are produced 









Figure 2.4: Formation of prevalent ROS from O2 (prepared by author). 
 
2.2.1.1. Sources of reactive oxygen species 
Reactive oxygen species are produced by endogenous and exogenous sources. The major 
intracellular producer of ROS is the ETC in the mitochondria. Complex I and III of the ETC 
produces O2•- anions. The Q cycle in the ETC also produces O2•- anions. The transfer of e-s from 
complex I or II to coenzyme Q (Q) results in the formation of reduced coenzyme Q (QH2). 
Coenzyme Q is regenerated via a reaction between QH2 and an unstable semiquinone anion         
(Q•-), which immediately transfers e-s to O2, forming O2•- (Figure 2.5). The Q cycle is non-
enzymatic, therefore increased respiration will lead to increased ROS production. Other 
mitochondrial components such as monoamine oxidase, p66sch and α-ketoglutarate 
dehydrogenase are also involved in the mitochondrial production of ROS (Phaniendra, Jestadi et 




Figure 2.5: Production of O2•- via the ETC in the inner mitochondrial membrane of the 
mitochondria (prepared by author). 
 
The respiratory burst produced by NADPH oxidase during the phagocytosis of microbes is the 
second major source of ROS in the body (Claudia Borza, Danina Muntean et al. 2013). 
Peroxisomes contain an array of enzymes that have been shown to produce various ROS.  The 
respiratory pathway in peroxisomes are also involved in the transfer of e- to various metabolites 
and leads to the formation of O2•-, OH•, and H2O2. β-oxidation of fatty acids within peroxisomes 
generate H2O2 as well (Noori 2012). The endoplasmic reticulum, lysosomes and various 
cytochromes also contribute to endogenous ROS (Claudia Borza, Danina Muntean et al. 2013).  
The body is subjected to assault from several agents that are capable of producing ROS. Cigarette 
smoke contains many free radicals such as O2•- and nitric oxide. Inhalation of smoke activates 
endogenous ROS producing mechanisms which further increase oxidative injury (Birben, Sahiner 
et al. 2012). Ultra violet and ionizing radiation induces the synthesis of ROS via photosensitizing 
agents. In the presence of O2, these photosensitizing agents convert O2•- and organic radicals to 
H2O2 and organic hydroperoxides. Hydroperoxides can react with active redox metals to induce 
oxidative stress (Claudia Borza, Danina Muntean et al. 2013).  
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Detoxification of consumed drugs by cytochrome P450-dependant enzymes lead to the activation 
of O2 and formation of ROS, which enhances lipid peroxidation (Claudia Borza, Danina Muntean 
et al. 2013). Exposure to O3 and enhanced atmospheric O2 levels also lead to lipid peroxidation 
and ROS formation (Birben, Sahiner et al. 2012). 
Lastly, the consumption of alcohol can initiate ROS synthesis by the activation of xanthine 
oxidase and aldehyde oxidase. The oxidation of acetaldehyde, the primary metabolite of ethanol, 
results in the formation of O2•- (Claudia Borza, Danina Muntean et al. 2013). 
2.2.1.2. Molecular targets of reactive oxygen species 
Reactive oxygen species readily reacts with biological macromolecules, resulting in oxidative 
modifications which promote the unfolding of proteins, shortening of telomeres, and destruction 
of lipids, nucleic acids, small organic molecules and much more (Phaniendra, Jestadi et al. 2015). 
A) Lipid peroxidation 
Lipids are a diverse group of organic compounds that form major building blocks of cell 
membranes, and are important in maintaining the structure and function of cells (Pamplona 2008). 
Lipids, especially those high in polyunsaturated fatty acids (PUFA) and cholesterol, are the most 
vulnerable to attacks by ROS, as free radicals can easily “steal” electrons from them. Oxidative 
degradation of lipids is known as lipid peroxidation and has been implicated with various 
pathological states (Yin, Xu et al. 2011). 
Lipid peroxidation is a complex process that is accomplished in 3 phases: initiation, propagation 
and decomposition (Figure 2.6) (Claudia Borza, Danina Muntean et al. 2013). It begins with the 
removal of allylic H atom from the PUFA moiety of lipids by ROO• or RO•.  The carbon-centred 
lipid radical (L•) that is formed reacts with O2 to form lipid peroxyl radical (LOO•). LOO• can 
further propagate the peroxidation process by removing hydrogen (H) atoms from adjacent PUFA 
moieties. Propagation occurs until O2 or un-oxidised PUFA moieties run out. Thereafter, LOO• 
undergo decomposition to form ROO• and RO• (Rice-Evans 1994). The accumulation of LOO•, 
ROO• and RO• accelerate the peroxidation of PUFA moieties and leads to the structural 
disorganization of cell membranes that may inhibit membrane bound receptors and enzymes, 
decrease lipid fluidity, alter membrane permeability and ion transport (Birben, Sahiner et al. 
2012). Cleavage of carbon double bonds during peroxidation results in the formation of reactive 
aldehydes such as malondialdehyde (MDA) and 4-hydroxynonenal (HNE). Malondialdehyde and 
HNE are the most commonly studied products of lipid peroxidation and are measured as markers 




Figure 2.6: ROS reacts with lipid membranes and generates reactive aldehydes including MDA 
and HNE, in three phase reactions (Shah, Mahajan et al. 2014). 
 
B) Protein oxidation 
Various ROS including the by-products of lipid peroxidation interact with proteins. This often 
leads to oxidative modifications to amino acid residues and cofactors. These modifications result 
in fragmentation of polypeptide chains, alteration in electrical charges, increased proteolysis and 
loss of protein function (Noori 2012).  
Sulphur-containing amino acids such as cysteine and methionine form key components of AO; 
regrettably these amino acids are the most susceptible to oxidation (Costa, Quintanilha et al. 
2007). Oxidation of cysteine and methionine form thiyl radicals and methionine sulphoxide 
respectively. Oxidation of sulphur containing amino acid residues cause conformational changes 
to protein structure, unfolding and degradation (Birben, Sahiner et al. 2012). 
Oxidation of basic amino acid and proline residues, as well as cleavage at acidic amino acid 
residues, lead to carbonylation of proteins (Birben, Sahiner et al. 2012). Carbonyl groups may 
also be incorporated into proteins via reactions with aldehydes produced during lipid 
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peroxidation. The formation of protein carbonyls is irreversible and is therefore used as a marker 
for protein oxidation (Berlett and Stadtman 1997, Costa, Quintanilha et al. 2007). 
Hydroxyl radicals are also involved in the cleavage of the polypeptide backbone by abstracting 
the α-H atom of amino acid residues. This results in the formation of carbon centred radicals, 
which react rapidly with O2 forming RO2•, ROOH and ultimately RO•. Alkoxyl and its 
intermediates can react with other amino acid residues forming new carbon centred radicals. The 
formation of RO• sets the stage for the cleavage of peptide bonds by either the diamide or α-amide 
pathways (Berlett and Stadtman 1997).  
Proteins, especially enzymes that undergo irreversible oxidation and fragmentation can no longer 
function effectively and must undergo proteolytic degradation. Failure to remove this ineffective 
proteins allow for oxidized proteins to become severely oxidized or cross-linked (Costa, 
Quintanilha et al. 2007).  
C) Deoxyribonucleic acid oxidation 
Deoxyribonucleic acid (DNA) consists of a double helix formed from two complementary strands 
of nucleotides held together by H bonds between pyrimidine [thymine (T) and cytosine (C)] and 
purine [guanine (G) and adenine (A)] pairs (Alberts B, Johnson A et al. 2002). However ROS can 
disrupt this double helix via base damage, base removal, DNA strand breaks, protein-DNA cross 
linkage, modifications to the sugar moiety, mutations, deletions and translocations (Bayir 2005). 
Most of these modifications have been linked with aging, cancer, autoimmune and 
neurodegenerative disorders (Birben, Sahiner et al. 2012) . 
Due to its low redox potential, G is the most vulnerable nucleobase to oxidation. The dominant 
product of G oxidation is 8-oxo-guanine (8-oxoG) (Figure 2.7) and is therefore used as a cellular 
biomarker of oxidative stress (Aguiar, Furtado et al. 2013). During DNA replication, DNA 
polymerase incorporates 8-oxoG into the nascent DNA strand. This modified nucleotide mimics 
T and thus produces the following transverse mutations: A:T to C:C or G:C to T:A. These 
mutations are possible due to the ability of 8-oxoG to pair with both cytosine and adenine (Barzilai 
and Yamamoto 2004). Transcription factor binding sites in the promoter regions of genes are 
especially prone to these mutations as they contain high GC rich sequences. Incorporation of 8-
oxoG or its mutations in the transcription factor binding sites can modify the binding of 
transcription factors and alter the expression of genes (Birben, Sahiner et al. 2012).  These 
mutations also promote the formation of DNA double strand breaks, which inactivate key genes, 
and initiates apoptosis. Removal of 8-oxoG is achieved by the base excision repair enzyme, 8-




Figure 2.7: Modification of guanine to 8-oxoG. The deoxy ribose sugar of DNA is represented 
by dR (prepared by author). 
 
2.2.2. Anti-oxidant response 
In order to combat excess ROS, cells are equipped with a well-balanced defence mechanism 
mediated by an endogenous AO system. Anti-oxidants are phenol containing compounds that 
inhibit the oxidation of substrates and/or neutralize the possible adverse-effects of ROS. 
Oxidation reactions can produce free radicals, which often initiate chain reactions that lead to cell 
injury (Noori 2012). Anti-oxidants are often termed reducing agents because they terminate these 
chain reactions by removing radical intermediates and inhibiting other oxidation reactions by 
being oxidized themselves (Lü, Lin et al. 2010).  
These free radical scavengers are present at low levels in plasma (e.g. β-carotene and ascorbic 
acid), cell membranes (e.g. α-tocopherol) and intracellularly [e.g. SOD and CAT] (Rahal, Kumar 
et al. 2014).   
2.2.2.1. Types of Anti-oxidants: 
Anti-oxidants can be classified into enzymatic AO and non-enzymatic AO. 
A) Enzymatic anti-oxidants: 
All cells in the body contain powerful AO enzymes. The 3 major classes of enzymatic AO are: 
SOD, CAT, and GPx (Noori 2012). Superoxide dismutase acts as the first line of defence, 




Superoxide dismutase is of primary importance in most cells as it catalyses the dismutation and 
removal of O2•- (Kabel 2014). It also repairs damage and reduces the harmful effects of the O2•- 
by converting it to the less damaging H2O2 (Figure 2.9). Metals such as copper (Cu), zinc (Zn), 
manganese (Mn) or iron (Fe) are incorporated into SOD. Super oxide dismutase incorporated with 
Cu or Zn are located in the cytosol, while Mn-SOD is abundant in the mitochondria and is also 
known as SOD2 (Birben, Sahiner et al. 2012). Iron incorporated SOD is localized in the extra-
cellular matrix. In the absence of SOD, non-enzymatic AO reduce O2•-  but at a much slower rate 
(Kabel 2014) . 
Although less harmful than O2•-, H2O2 damages enzymes by oxidizing thiol groups and iron-
sulphur centres. If not detoxified, H2O2 can also be further converted to OH• that often causes 
mutagenic and lethal lesions. Therefore CAT and GPx are important in catalysing the degradation 
of H2O2 to H2O and O2 (Sharma, Jha et al. 2012). 
Catalase has one of the highest turnover rates of all enzymes; one molecule of catalase can 
detoxify millions of H2O2 molecules. Catalase consists of four 500 amino acid long polypeptide 
chains and four porphyrin heme containing rings that are able to react with H2O2. It is highly 
expressed in peroxisomes of all cells with the exception of erythrocytes  and can detoxify H2O2 
in two manners i.e. catalytic manner and peroxidatic manner (Figure 2.8) (Kabel 2014). The 
catalytic manner catalyses the conversion of H2O2 into H2O and O2, while the peroxidatic manner 
involves CAT reacting with H-donors such as methanol and ethanol. By doing so, CAT oxidizes 
these substrates by using an O2 molecule from one molecule of H2O2 and in the process H2O2 is 
converted to water (Sichak and Dounce 1986).  
 
Figure 2.8: The catalytic (A) and peroxidatic (B) manner of CAT action (prepared by author). 
17 
 
The second H2O2 detoxifying enzyme is GPx. It contains the unique amino acid selenocytesteine 
in its active sites and uses low molecular weight thiols such as glutathione as cofactors to convert 
H2O2 (Figure 2.9) and lipid peroxides to H2O and its corresponding alcohols. Four GPx isoforms 
have been identified, cellular GPx (GPx-1), gastrointestinal GPx (GPx-2), extracellular GPx 
(GPx-3) and membrane-bound GPx (GPx-4) (Birben, Sahiner et al. 2012). 
 
Figure 2.9: The detoxification of O2•- and H2O2 by major enzymatic AO (prepared by author). 
 
B) Non-enzymatic anti-oxidants: 
A large number of lipid/water soluble compounds have shown some measure of AO activity. 
Most non-enzymatic AO cannot be synthesized by the human body and are thus obtained from 
the diet. Major non-enzymatic AO include reduced glutathione (GSH), vitamin A, vitamin C, and 
vitamin D (Noori 2012).  
Vitamin C (ascorbate) acts as a pro-oxidant and AO. In the presence of transition metals, vitamin 
C can generate oxygen free radicals. As an AO vitamin C work synergistically with vitamin E to 
reduce oxidised vitamin E and restore its AO properties (Patekar, Kheur et al. 2013). 
Vitamin E (tocopherols and tocotrienols) is an important lipophilic AO which is localized in cell 
membranes. It defends membranes and lipids against peroxides by donating an e- to peroxyl 
radicals that are produced during lipid peroxidation chain reactions. In the process, vitamin E is 
oxidised to quinone; however, vitamin C is able to reverse the oxidation of vitamin E (Birben, 
Sahiner et al. 2012). 
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β-Carotene, a vitamin A precursor, also has both pro-oxidant and AO effects. At high O2 
concentration it functions as a pro-oxidant but at low O2 concentrations it protects membranes 
against lipid peroxidation by scavenging peroxyl, OH• and O2•- radicals (Patekar, Kheur et al. 
2013).  
The tripeptide, glutathione is often referred to as the body’s master AO. It can be present in its 
reduced state – GSH; or oxidised state (GSSG). The GSH/GSSG ratio is often used as an indicator 
of oxidative stress (Filomeni, Rotilio et al. 2002). Reduced glutathione directly quenches OH•, 
and other oxygen-centred free radicals. It also acts a cofactor for thiol containing AO enzymes 
such as GPx and is involved in converting vitamin C and vitamin E back to their active, reduced 
states (Birben, Sahiner et al. 2012).  
The GSH/GSSG ratio is often maintained by the recycling of GSSG back to GSH. The enzymatic 
AO, GPx often uses GSH as a substrate in the detoxification of peroxides such as H2O2 and lipid 
peroxides (Figure 2.10). This results in the generation of GSSG, which is subsequently reduced 
by glutathione reductase (GR) in a reaction that requires NADPH (Lushchak 2012). 
 
Figure 2.10: The GSH redox cycle (prepared by author). 
 
2.2.2.2. Nuclear-factor-erythroid 2 p45-related factor 2: Master regulator of the anti-oxidant 
response 
 Numerous regulators of the AO exist but none are as important as the Nrf2-ARE signalling 
pathway (Itoh, Tong et al. 2004). As a basic leucine zipper transcription factor, Nrf2 integrates 
cellular stressors and responds by promoting the transcription of phase II and III detoxifying 
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enzymes, cellular regenerating enzymes, xenobiotic metabolising enzymes and AO (Jaramillo 
and Zhang 2013). 
Under basal physiological conditions, Nrf2 is sequestered in the cytoplasm, and undergoes 
constant degradation through Kelch-like ECH associated protein 1(Keap-1) ubiquitination. It was 
initially thought that the binding and tethering of Keap-1 to Nrf2 was involved in Nrf2 repression 
(Zhang 2006); however, recent studies have demonstrated that Keap-1 does not only passively 
sequester Nrf2 to the cytoplasm but interacts with the Nrf2-ECH homolog h2 (Neh2) domain of 
Nrf2. The Neh2 domain contains several lysine residues that are targets for ubiquitination by 
Keap-1 via cullin 3 (CUL3) ubiquitin ligase (Rojo de la Vega, Dodson et al. 2016). 
Electrophilic species (ES) and ROS disrupts the Keap-1 dependant repression of Nrf2, allowing 
cytoplasmic accumulation and subsequent nuclear translocation of Nrf2 (Figure 2.11). The 
twenty-seven cysteine residues of Keap-1 are attractive targets for ROS and ES. Oxidative 
modification of these cysteine residues, results in structural modifications to Keap-1, weakening 
its activity as a ligase adaptor (Sporn and Liby 2012).  This leads to the dissociation of Keap-1 
from the Neh domain, allowing the accumulation of Nrf2 in the cytosol. Modifications to Nrf2 
indirectly by ROS such as the phosphorylation of Nrf2’s serine 40 also induces the dissociation 
of Nrf2 from Keap-1 (Huang, Nguyen et al. 2002). The now stabilized Nrf2 translocates to the 
nucleus where it binds to the ARE of its target gene. It cannot bind directly to the ARE as a 
monomer or homodimer; Nrf2 must first dimerize with small Maf proteins. The Nrf2-Maf dimers 
bind to the ARE, inducing the transcription of its target AO genes (Figure 2.11) (Nguyen, Nioi et 




Figure 2.11: The repression and activation of Nrf2 by Keap-1 (prepared by author). 
 
2.2.3. Mitochondrial response 
Dysregulation of the ETC in the mitochondria enhances the generation of ROS within the 
mitochondrial matrix. In order to defend itself against oxidative damage, the expression of certain 
proteins are upregulated. The proteins include: Tfam, Sirt 3 and Lon-P1 and contribute to 
mitochondrial well-being under oxidative stress. 
Sirtuin 3 is a nicotinamide adenine dinucleotide (NAD+)-dependant proteins that belongs to the 
silent information regulator 2 (SIR2) family. As it found exclusively in the mitochondria, Sirt 3 
can regulate many central aspects of mitochondrial function including metabolism, ATP 
generation and oxidative stress responses (Ansari, Rahman et al. 2017). Oxidative stress 
stimulates Sirt 3 transcription which leads to the deacetylation of the mitochondrial AO, SOD2. 
The deacetylation of SOD2 significantly enhances its ability to scavenge ROS. Deacetylation and 
activation of isocitrate dehydrogenase 2 (IDH2) by Sirt 3 is also able to alleviate oxidative stress. 
Although IDH2 does not have any direct AO capabilities, it catalyzes the conversion of isocitrate 
to α-ketoglutatrate; which produces nicotinamide adenine dinucleotide phosphate (NADPH). 




Lon-protease 1 is also post-transcriptionally regulated by Sirt 3 (Gibellini, Pinti et al. 2014). 
Proteins within the mitochondrial are continuously exposed to ROS. Oxidative damage to proteins 
can lead can cause aggregation of proteins, formation of adducts, and ultimately lead to cellular 
dysfunction (Pinti, Gibellini et al. 2015). Damaged proteins are selectively degraded by the ATP-
dependant Lon-P1; which is post-transcriptionally regulated by Sirt 3 (Gibellini, Pinti et al. 2014). 
The regulation of Lon-P1 is bi-phasic as it is highly inducible under transient stress, however 
Lon-P1 levels decline under chronic stress conditions (Ngo, Pomatto et al. 2013). Furthermore, 
Lon-P1 is involved in the regulation of mitochondrial gene expression and controls mtDNA copy 
number by degrading Tfam (Lu, Lee et al. 2013).   
The mitochondrial transcription factor, Tfam is a member of the high mobility group (HMG) 
proteins. It is capable of binding, wrapping, bending and unwinding DNA regardless of sequence 
specificity (Istiaq Alam, Kanki et al. 2003). The close proximity of mtDNA to the ETC, makes it 
is prone to attacks by ROS. Therefore mtDNA is localized in a nucleoid structure to prevent DNA 
oxidation. The transcription of components that form the nucleoid is activated by Tfam. 
Furthermore, Tfam binds directing to DNA giving it additional protection from oxidative damage 
(Kanki, Ohgaki et al. 2004).  
 
2.3. The role of oxidative stress in cancer 
Cancer is a complex disease in which cells undergo profound metabolic and behavioural 
alterations that allow for uncontrolled cell growth and ability to escape immune surveillance. 
(Gorrini, Harris et al. 2013). It a multi-step process that consists of 3 stages: initiation, promotion 
and progression. Oxidative stress is involved in all 3 stages of cancer development. At low 
concentrations ROS can initiate carcinogenesis by modifying DNA which leads to gene 
mutations; or they can act as a signalling molecule that activate molecules linked with cancer cell 
growth and survival such as mitogen-activated protein kinase (MAPK) and Cyclin D1 (Reuter, 
Gupta et al. 2010, Sosa, Moliné et al. 2013). The promotion stage is characterised by increased 
cell proliferation and decreased apoptosis. Reactive oxygen species contributes to this through 
the disruption of cell to cell communication, induction of abnormal gene expression, modification 
of second messenger systems and activation of extracellular-regulated kinase 1/2 (ERK1/2) 
(Reuter, Gupta et al. 2010). Further DNA alterations by ROS in the rest of cell population leads 
to the final stage – progression (Reuter, Gupta et al. 2010). High levels of ROS also contributes 
to tumour invasion and metastasis through the overexpression of matrix metalloproteinase (MMP) 
and its secretion into the extracellular matrix (Sosa, Moliné et al. 2013).  
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At very high concentrations, however, ROS causes cells to detach from the cell matrix, induces 
severe cell damage and promotes cell death. Cancer cells have a high AO capacity that regulates 
ROS to levels that are beneficial to the cancer cell but at the same time higher than normal cells 
(Sosa, Moliné et al. 2013).  
Like ROS, Nrf2 has both oncogenic and tumour suppressing properties. Nrf2 is important in 
supressing carcinogenesis during its early stages (Sporn and Liby 2012). Knock out studies 
involving Nrf2 in mice have shown that Nrf2 protects against tumorigenesis in the stomach, 
bladder and skin. Further evidence supporting the protective role of Nrf2 comes from studies with 
mice that contain polymorphisms in the promoter regions of the Nrf2 gene. These mice had 
reduced Nrf2 expression and increased susceptibility to non-small cell lung cancer (Jaramillo and 
Zhang 2013).  
In addition to promoting the survival of healthy cells, prolonged activation of Nrf2 promotes the 
survival of cancer cells as well. Prolonged Nrf2 activation favours the proliferation of lung, breast, 
ovarian and endometrial cancer cells by promoting the transcription of genes that support glucose 
flux and generate the building blocks of macromolecules (Gorrini, Harris et al. 2013, Jaramillo 
and Zhang 2013). The ability of Nrf2 to induce AO-responses that maintain balance between 
redox levels that initiate cell death and promote cancer cell survival is also important (Gorrini, 
Harris et al. 2013). 
The role of oxidative stress and the activation of Nrf2 in relation to tumorigenesis is of current 
interest amongst researchers. While it is known that FB1 is linked to tumorigenesis, the underlying 
mechanism of its cancer promoting properties are not well established. Therefore the focus of this 
study was to investigate the effect of FB1 on oxidative stress-related survival responses in HepG2 











CHAPTER 3 – MATERIALS AND METHOD 
3.1. Materials 
Fumonisin B1 (FB1), isolated from Fusarium moniliforme, was obtained from Sigma-Aldrich (St 
Louis, MO, USA). The human heptatocellular carcinoma (HepG2) cell line was acquired from 
Highveld Biologicals (Johannesburg, South Africa). Cell culture reagents and supplements were 
purchased from Lonza BioWhittaker (Basel, Switzerland). Western blot reagents were procured 
from Bio-Rad (Hercules, CA, USA) and anti-bodies were purchased from Abcam (Cambridge, 
UK), Sigma-Aldrich (St Louis, MO, USA), Cell Signalling Technologies (Danvers, MA, USA) 
and Santa Cruz (Dallas, TX, USA). All other reagents were purchased from Merck (Darmstadt, 
Germany) unless otherwise stated. 
3.2. Cell Culture 
The liver is the first site of detoxification of harmful substances including FB1. Exposure to the 
highly hepatotoxic FB1 has been a reported cause of hepatocarcinogenicity. The liver also has a 
high density of mitochondria which regulates a variety of functions including cell survival and 
detoxification. It is for these reasons that the HepG2 cell line was used in this study. 
3.2.1. Cell culture conditions 
 The HepG2 cells were cultured in monolayer (106 cells per 25cm3 culture flask) using complete 
culture media [CCM: Eagle’s Essential Minimal Media (EMEM) supplemented with: 10% foetal 
calf serum, 1% penstrepfungizone, and 1% L-glutamine] at 37°C in a humidified incubator. Every 
second day, cells were rinsed with 0.1M phosphate buffered saline (PBS) and reconstituted with 
CCM (5ml). 
3.2.2. Preparation of Fumonisin B1 
A 5mM stock of FB1 was prepared by dissolving 2mg FB1 in 0.1M PBS (554.2µl).  
3.2.3. Cell preparation for assays 
Cells were allowed to reach 80% confluence in 25cm3 flasks before treatment. An inhibitory 
concentration of 50% (IC50: 200µM) at 24 hours (h) was obtained from literature (Chuturgoon, 
Phulukdaree et al. 2014) and used in all subsequent assays. An untreated control, containing only 
CCM, was also prepared. 
 After the 24h incubation, cells were detached by trypsinisation and agitation; the Trypan Blue 
exclusion method of cell counting was employed to determine cell viability and cell number as 
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required per assay performed (Strober 2001). The control was used for statistical comparison 
against FB1 treatment and all experiments were done in triplicate, independently from each other. 
3.3. 2′,7′-dichlorodihydrofluorescein-diacetate assay 
3.3.1. Principle 
Intracellular ROS was quantified by the simple, yet sensitive fluorometric 2′,7′-
dichlorodihydrofluorescein-diacetate (H2DCF-DA) assay. Cells are treated with the membrane 
permeable, non-fluorescent H2DCF-DA probe (Wan, Zhou et al. 2005). Once H2DCF-DA is 
inside the cell; it is deacetylated to 2’,7’-dichlorfluorescein (DCFH), which is also non-
fluorescent. Within the cell, DCFH undergoes two e- oxidation by ROS to form the fluorescent, 
2’,7’-dichlorodihydrofluorescein (H2DCF). The fluorescence produced by H2DCF can be 
measured using flow cytometry, luminometry or microscopy. (Kalyanaraman, Darley-Usmar et 
al. 2012). 
3.3.2. Protocol 
Control and treated cells (50 000 cells per treatment) were incubated in 500µl of 5µM H2DCF-
DA stain (30 minutes [min], 37°C). The stain was removed via centrifugation (400xg, 10min,       
24°C) and washed twice with 0.1M PBS. Cells were resuspended in 400µl of 0.1M PBS and 
seeded in triplicate (100µl/well) in a 96-well opaque microtiter-plate. A blank consisting of only 
PBS was plated in triplicate as well. The fluorescence produced by cells were read on a 
ModulusTM microplate luminometer (Turner Biosystems, Sunnyvale, CA) using a blue filter with 
an excitation wavelength of 503nm and emission wavelength of 529nm. The fluorescence of each 
sample was calculated by subtracting the average fluorescence of the blank from the fluorescence 
of each sample. 
3.4. Thiobarbituric acid reactive substances assay 
3.4.1. Principle 
A well-used method for assessing oxidative damage in cells is the thiobarbituric acid reactive 
substances (TBARS) assay, which quantifies a by-product of lipid peroxidation –
malondialdehyde (MDA). This assay is based on the formation of a chromogenic adduct of 
thiobarbituric acid (TBA) with MDA. One molecule of MDA undergoes nucleophilic attack by 
two molecules of TBA to yield a pink chromogen with an absorbance maximum of 532nm (Figure 
3.1). The reaction takes place optimally under high temperatures (90-100°C) and acidic conditions 




Figure 3.1: The reaction between 2-TBA and MDA during the TBARS assay (prepared by 
author). 
 
Phosphoric acid (H3PO4) provides the acidic environment, while TBA from thiobarbituric 
acid/butylated hydroxytoluene (TBA/BHT) reagent detects MDA found in the sample. Formation 
of non-specific chromophores are inhibited by BHT and butanol is used to extract the MDA-TBA 
adduct from the sample (Grotto, Maria et al. 2009) . 
A positive control and blank are usually prepared along with the samples. The blank does not 
contain any MDA and assesses contamination of reagents that would otherwise give false 
positives. The positive control, which contains MDA, evaluates whether the experimental 
procedure was done correctly.  
 
3.4.2. Protocol 
Four glass test tubes were prepared: positive control, negative control (blank), untreated control 
and treatment. Supernatant (400µl) from control and FB1-treated cells were dispensed into the 
respective test tubes. Phosphoric acid (H3PO4) (7%, 200µl) was dispensed into each test tube, 
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followed by TBA/BHT (200µl). Instead of TBA/BHT, hydrogen chloride (HCl) (3mM, 400µl) 
was added to the negative control and MDA (1µl) to the positive control. The pH of all samples 
were adjusted to pH 1.5 using 1M HCl and samples were boiled for 15min. Once cooled to room 
temperature (RT), the MDA-TBA adducts were extracted using butanol (1.5ml) and samples were 
allowed to settle until two distinct phases were visible. The butanol phase (500µl) from each 
sample was dispensed in triplicate into a 96-well microtiter plate. The optical density was 
measured using a spectrophotometer (Bio-Tek μQuant, Winooski, VT, USA) at 532nm and a 
reference wavelength of 600nm. The concentration of MDA in samples were calculated using 
equation 3.1  (Devasagayam, Boloor et al. 2003).  
 
 
3.5. Protein Isolation, quantification and standardization 
3.5.1. Principle 
Protein was isolated for both the protein carbonyl assay (PCA) and western blotting. The isolation 
process was carried out on ice to prevent proteins from degrading. Crude protein was quantified 
and standardized to ensure that the protein concentration was sufficient to carry out the assays 
and to ensure that comparisons between samples could be made (Huang, Long et al. 2010).  
Protein concentration was determined using the highly sensitive, bicinchoninic acid (BCA) assay. 
This assay relies on two chemical reactions that take place under alkaline conditions. The first 
reaction is known as the biuret reaction and involves the reduction of cupric ions (Cu2+) to cuprous 
ions (Cu1+) by peptide bonds (Figure 3.2). This is followed by the chelation of Cu1+ with two 
molecules of BCA resulting in the formation of an intense purple chromophore, which has an 
absorbance maximum of 562nm. The protein present in the sample is directly proportional to the 
reduction of Cu2+. Furthermore, the protein concentration of samples can be determined by 
comparing their absorbance values with the absorbance values obtained from the bovine serum 
standards (BSA) (Huang, Long et al. 2010). 
Equation 3.1: Calculation used to determine the MDA concentration (in mM), where 156mM-1 is the 
extinction co-efficient of the MDA-TBA adduct (Devasagayam, Boloor et al. 2003). 
MDAConcentration= 






Figure 3.2: The principle of the BCA assay used to quantify proteins. Reaction A represents the 
reduction of Cu2+ and reaction B represents the chelation of BCA to Cu1+ (prepared by author). 
 
3.5.2. Protocol 
Protein was isolated using cell lysis buffer (200µl) for the PCA assay and 200µl of Cytobuster™ 
(Novagen, USA) supplemented with protease and phosphatase inhibitors (Roche, 05892791001 
and 04906837001, respectively) for western blotting.  
Cells were incubated in lysis solutions on ice for 10min, then mechanically lysed and decanted 
into micro-centrifuge tubes. The cell lysate was centrifuged (13 000xg, 10 min, 4°C) to obtain 
crude protein; which was quantified using the BCA assay. 
Bovine serum albumin (BSA) standards (0–1 mg/ml) were prepared and 25µl of sample 
(duplicate) and standards (triplicate) were dispensed into a 96-well microtiter plate.  BCA 
working solution (196µl BCA: 4µl CuSO4 per well) was dispensed into each well, followed by a 
30min incubation at 37°C. The optical density of the samples were measured at 562nm using a 
spectrophotometer (Bio-Tek μQuant). The mean absorbance values of the standards were used to 
construct a standard curve, which determined the protein concentration of the samples. Quantified 
proteins were standardised to 1mg/ml using cell lysis buffer for PCA, whereas protein required 




3.6. Protein Carbonyl Assay 
3.6.1. Principle 
Protein oxidation was measured by quantifying intracellular protein carbonyl groups. The 
carbonylation of protein represents the introduction of carbonyl groups (aldehyde or ketone) into 
the protein structure, through several mechanisms: 1) direct oxidation of specific amino acid 
residues from the protein chain, 2) interaction of lipid peroxidation products and aldehyde groups 
(such as 4-hydroxy-2-nonenal, MDA, 2-propenal), 3) the interaction of carbonyl groups, formed 
from the degradation of lipids or glycoxidation. The aforementioned molecular changes occur 
during oxidative stress. In comparison to other oxidative changes, the carbonylation process is 
irreversible, therefore the final compounds are stable and can be quantified (Purdel, Margina et 
al. 2014). 
The standard method for assessing protein carbonyls involves the derivatisation of the carbonyl 
groups with 2,4-dinitrophenylhydrazine (DNPH) in order to obtain 2,4-dinitrophenylhydrazones 
(DNP). This stable product (yellow) has an absorption maximum at 370 nm and can be quantified 
spectrophotometrically (Figure 3.3) (Purdel, Margina et al. 2014). 
Figure 3.3: The formation of DNP-derived protein used the detection of protein carbonyl groups 
(prepared by author). 
3.6.2. Protocol 
Standardised protein was incubated at RT for 1h with DNPH (800µL). A blank, containing 
standardized protein from control cells and 2.5M HCl (800µl) was also prepared. Proteins were 
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precipitated with 20% Trichloroacetic acid (1ml), vortexed and centrifuged (2 000xg, 10min, 
24°C). The pellet was washed twice with 1ml ethanol-ethyl acetate (1:1), this eliminated traces of 
DNPH and solubilized residual lipids. Lastly, proteins were dissolved in 6M guanidine HCl (1ml). 
Samples were incubated (10min, 37°C) before any insoluble material was removed with 
centrifugation (2 000g, 10min, 24°C). The supernatant was collected and dispensed in triplicate 
in 96-well plate (100µl/well). Absorbance was measured at 370nm using a spectrophotometer and 
carbonyl content was calculated using equation 3.2 (Mercier, Gatellier et al. 2004). 
 
3.7. Reduced glutathione assay 
3.7.1. Principle 
Glutathione is an important endogenous AO that is composed of glutamate, cysteine and glycine. 
It exists in either its active reduced state (GSH) or oxidised state (GSSG). Reduced GSH acts as 
an e- donor to detoxify ROS, yielding GSSG. Recycling of GSH/GSSG is regulated by the 
enzymes: GPx, glutathione-s-transferase (GST), glutathione reductase (GR) and glucose-6-
phospate dehydrogenase to neutralize ROS (Figure 3.4) (Rahman, Kode et al. 2007). 
 
Figure 3.4: The glutathione cycle (prepared by author). 
𝑪𝒂𝒓𝒃𝒐𝒏𝒚𝒍 𝑪𝒐𝒏𝒄𝒆𝒏𝒕𝒓𝒂𝒕𝒊𝒐𝒏 (µ𝑴) =




Equation 3.2: Calculation used to determine the protein carbonyl concentration of cells (in µM), where 1cm 
is the path length and 22 000M-1cm-1 is the extinction co-efficient of DNP (Mercier, Gatellier et al. 2004). 
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The GSH-Glo® assay is a chemi-luminescent assay that is based on the oxyluciferin-luciferase 
system. Luciferin-NT is converted to Luciferin, resulting in the consumption of GSH and release 
of ATP and O2. Thereafter, luciferase reacts with luciferin to produce a photon of light which can 
be detected by a luminometer (Figure 3.5). The amount of light produced is directly proportional 
to the concentration of GSH in the cell (Rahman, Kode et al. 2007).  
 
Figure 3.5: The light producing reaction between GSH and luciferin (prepared by author). 
  
3.7.2. Protocol 
Control and treated cells were transferred to an opaque microtitre plate (50µl of 20 000 cells/well 
in 0.1M PBS) in triplicate. Standards (0-50µM) were prepared from a 5mM stock of GSH using 
deionized water and dispensed in triplicate. GSH-Glo reaction solution (50µl) were added to each 
well and the plate was left in the dark (RT, 30min). After the 30min incubation, luciferin detection 
reagent (100µl) was dispensed into each well and the plate was incubated (RT, 15min). The plate 
was read on a ModulusTM microplate luminometer (Turner Biosystems, Sunnyvale, CA). A 
standard curve was generated using the standards and the GSH concentration (µM) of the sample 




3.8. Catalase activity assay 
3.8.1. Principle 
Anti-oxidants (AO) are essential in inhibiting or delaying the effects of excessive ROS. Assessing 
the AO capacity of cells can be used as an indicator for the occurrence of oxidative stress. Catalase 
(CAT) is a primary endogenous AO that detoxifies excess H2O2 to H2O and O2. A simple 
qualitative procedure using Triton X-100 and H2O2 can be used to assess catalase activity of cells. 
The O2 bubbles generated from the decomposition of H2O2 by CAT (obtained from cells) are 
trapped by the surfactant Triton X-100.  The trapped O2 bubbles are visualized as foam, the test-
tube height of which is measured to quantify the CAT activity (Iwase, Tajima et al. 2013). 
3.8.2. Protocol 
Cells were washed twice via centrifugation (400xg, 10min, 24°C) and resuspended in 0.1M PBS 
(400µl). The cell suspension (100µl) was pipetted into test tubes in triplicate. Triton X-100 (1%, 
100µl) was added to all samples, followed by H2O2 (30%, 100µl). Samples were mixed 
thoroughly and incubated at RT for 20min. Once samples stopped bubbling, the height of the 
foam produced was measured. A blank consisting of Triton x-100 and H2O2 was prepared along 
with samples. Catalase activity was calculated using equation 3.3. 
𝐶𝒂𝒕𝒂𝒍𝒂𝒔𝒆 𝒂𝒄𝒕𝒊𝒗𝒊𝒕𝒚 (%) =
𝑯𝒆𝒊𝒈𝒉𝒕 𝒐𝒇 𝒃𝒖𝒃𝒃𝒍𝒆𝒔
𝑯𝒆𝒊𝒈𝒉𝒕 𝒐𝒇 𝒓𝒆𝒂𝒄𝒕𝒊𝒐𝒏 𝒎𝒊𝒙𝒕𝒖𝒓𝒆 + 𝑯𝒆𝒊𝒈𝒉𝒕 𝒐𝒇 𝒃𝒖𝒃𝒃𝒍𝒆
× 𝟏𝟎𝟎 
Equation 3.3: Equation used to calculated CAT activity. Results were expressed in percentage 
(%). 
3.9. Sodium dodecyl sulphate–polyacrylamide gel electrophoresis and Western Blotting 
3.9.1. Principle 
Sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting 
are powerful techniques used for the identification of proteins. It involves the separation of 
proteins based on their molecular weight, transfer of these proteins onto a membrane and detection 
of a specific protein using immunoblotting (Kurien and Scofield 2006). 
A) Sample preparation 
Before separation by electrophoresis can occur, standardized proteins are prepared in Laemmli 
buffer and boiled for 5min in a 100°C water bath. Each component of Laemmli buffer serves a 
specific function that allows for optimum electrophoresis (Table 3.1). The high temperature from 
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boiling promotes the denaturation of proteins and breakage of disulphide bonds. (Mahmood and 
Yang 2012). 
Table 3.1: Components of Laemmli buffer with their respective functions. 
Component Function 
Glycerol Adds density to the sample, allowing the sample to sink 
easily into the wells of the gel. 
Sodium dodecyl sulphate (SDS) Denatures proteins and imparts a negative charge onto them. 
β-mercaptoethanol  Reduces disulphide bridges allowing for unfolding. 
Bromophenol blue  Tracks migration of sample during electrophoresis. 
Tris–HCl  Serves as a buffer and maintains pH of proteins during 
electrophoresis. 
 
B) Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis 
Proteins were separated based on their molecular weight using SDS-PAGE. Charged molecules 
usually migrate in an electric field towards the electrode of the opposite charge. Denaturing 
samples in Laemmli buffer containing of SDS ensures that all proteins are uniformly charged 
(negative charge) and consequently migrate towards the positive electrode. Laemmli buffer also 
ensures proteins are in their primary form, allowing for separation to occur based on the molecular 
weight of the proteins and not their shape or charge (Mahmood and Yang 2012). 
Proteins migrate through polyacrylamide gels, which are polymers formed by the crosslinking of 
acrylamide with N, N’-methylene bis-acrylamide. These crosslinks impede the migration of 
molecules based on their size. High percentage gels, have more crosslinks and allow for smaller 
molecules to pass through. Conversely, low percentage gel have larger pores and allow for larger 
molecules to pass through. Two types of gels are used in SDS-PAGE: resolving gel and stacking 
gel. The resolving gel is cast first and has a high polyacrylamide content therefore it has smaller 
pores, allowing better separation of proteins based on their size (Figure 3.6). In contrast to the 
resolving gel, the stacking gel has a low polyacrylamide content and therefore larger pores. These 
large pores separate proteins poorly however it serves as a start line that ensures separation begins 
at the same point (Mahmood and Yang 2012).  
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Figure 3.6: Migration of proteins through gel layers based on size (prepared by author). 
 
C) Western blotting 
Once proteins are separated; western blotting allows for the transfer of proteins from the 
polyacrylamide gel to a solid support such as a nitrocellulose membrane. The electrophoresed gel 
and membrane are sandwiched between two fibre pads and plate electrodes, which allows for 
uniform transfer to occur. An electric currents is applied perpendicular to the surface of the gel 
prompting negatively charged proteins to migrate out of the gel and onto the nitrocellulose 
membrane (Kurien and Scofield 2006). 
After transfer, proteins of interest are detected using specific antibodies. A species specific 
primary antibody binds to the protein of interest on the membrane, while the secondary antibody 
probes for the bound primary antibody. This secondary antibody in conjugated with horse radish 
peroxidase (HRP), which emits a signal when the secondary antibody binds to the primary 
antibody (Figure 3.7). The intensity of the emitted light is directly proportional to the expression 
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of the protein of interest. Chemiluminescent detection reagent is used to amplify the signal 




A) Sample preparation 
Laemmli buffer [dH2O, 0.5M Tris-HCl (pH6.8), glycerol, 10% SDS, β-mercaptoethanol, and 1% 
bromophenol blue] was added to standardized proteins and boiled for 5min in a 100°C water bath. 
B) Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis 
Gels for SDS-PAGE were prepared using the Mini-PROTEAN Tetra Cell casting frame (Bio-
Rad). A 10% resolving gel [dH2O, Tris (1.5M, pH 8.8), SDS, Bis-acrylamide, Ammonium 
persulphate (APS), Tetramethylethylenediamine (TMED)] was prepared and allowed to 
polymerize for 1h. Thereafter, a 4% stacking gel [dH2O, Tris (0.5M, pH 6.8), SDS, Bis-
acrylamide, APS, and TEMED] was cast on top of the resolving gel. A 1cm plastic comb was 
placed between the glass plates to enable the formation of wells and the gel was allowed to set 
(40min). 
Once the stacking gel was set, the gel cassettes were transferred into the electrode assembly stand 
and placed in the electrode tank (Mini-PROTEAN Tetra Cell System, Bio-Rad). Running buffer 
(25mM Tris, 192mM glycine and 0.1% SDS) was poured into the tank, the combs were removed 
and protein samples (25µl) along with a molecular weight marker (5µl) (Precision Plus Protein 
Figure 3.7: Signal emission after immunoblotting (prepared by author). 
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All Blue Standards, catalogue no. #161-0373, Bio-Rad) were loaded into the wells. The tank was 
topped with running buffer and the samples were electrophoresed [150 volts (V), 1h] using Bio-
Rad compact power supply; whilst kept on ice. 
C) Western blotting 
Electrophoresed gels, fibre pads and nitrocellulose membranes were placed in transfer buffer 
(25mM Tris, 191.8mM glycine and 20% methanol) for 10min to equilibrate. Thereafter a gel 
sandwich consisting of a fibre pad, nitrocellulose membrane, gel and fibre pad was prepared and 
placed between the two electrodes of the transfer apparatus and the separated proteins were 
electro-transferred onto the nitrocellulose membrane using the Bio-Rad Trans-Blot Turbo 
Transfer System (30 min, 20V). 
After transfer, membranes were blocked in 5ml of blocking solution consisting of either 5% BSA 
or 5% non-fat dry milk (NFDM) in Tween 20-Tris buffered saline [TTBS: 150mM NaCl, 3mM 
KCl, 25mM Tris, 0.05% Tween 20, dH2O, pH 7.5] for 1h at RT with gentle shaking to prevent 
non-specific binding of proteins. Immunoblotting of the membranes with primary antibodies 
(Table 3.2) occurred overnight (4°C). Following overnight incubation, membranes were 
equilibrated to RT, primary antibodies were discarded and membranes were washed using TTBS 
(5 times, 10 minutes). Membranes were subsequently probed with a HRP-conjugated secondary 
antibody (Table 3.2) for 2h at RT with gentle shaking. TTBS was used to wash membranes (5 
times, 10 minutes) and protein bands were visualized using Clarity Western ECL Substrate 
detection reagent (BioRad, Hercules, USA). Images were captured using the Bio-Rad Chemidoc 
gel documentation system. 
After detection, membranes were quenched with 5% H2O2 for 30min, incubated in blocking 
solution (5% BSA for 1h at RT), rinsed thrice in TTBS and probed with HRP-conjugated anti-β-
actin (housekeeping protein). Protein expression was analysed using the Image Lab Software 
version 5.0 (Bio-Rad) and the results were expressed as relative band density (RBD). The 
expression of proteins of interest were normalised against β-Actin by dividing the RBD of the 
protein of interest by the RBD of β-actin.  
The expected size of proteins probed for is as follows: pNrf2 – 68kDa; Nrf2 – 68kDa; SOD2 – 
28kDa; CAT – 60kDa; Sirt 3 – 50kDa; Lon-P1 – 106kDa; c-Myc -57kDa; p-ser20-p53 – 53kDa; 





Table 3.2: Antibodies and antibody dilutions used in western blotting. 












1:1 000 in 
5% BSA 
ab76026 (Abcam) 
Rabbit Anti-Nrf2 1:1 000 in 
5% BSA 
ab31163 (Abcam) 
























































3.10. Real time quantitative polymerase chain reaction 
3.10.1. Principle 
Conventional polymerase chain reaction (PCR) is used for the rapid amplification of specific gene 
sequences. The thermostable Taq polymerase drives the synthesis of complementary DNA 
(cDNA) strands by adding deoxyneculoside triphosphates (dNTPs) to oligoneucloside primers 
that are complementary to the DNA sequence flanking the target gene (Pestana, Belak et al. 2010). 
For PCR to occur, the following components are necessary: 
 DNA template – Contains the target sequence 
 Forward and Reverse primers – Binds to the 3’ ends of the forward and reverse strands 
of the target sequence 
 Taq polymerase – Catalyses the synthesis of new strands of DNA complementary to the 
target sequence 
 Deoxynucleoside triphosphates (dNTPs) –Building blocks required for the synthesis of 
new DNA strands 
 MgCl2 – Stabilizes DNA and ensures the optimal functioning of Taq polymerase 
 Buffer system – Maintains optimum pH for PCR reaction to occur 
 
The PCR reaction is performed in a thermocycler where it undergoes repetitive cycling of three 
steps at different temperatures. The three steps include: denaturation, annealing and extension 
(Figure 3.8). Denaturation is initiated at 95°C and ensures that the H bonds between double 
stranded DNA are broken, producing single stranded DNA. The temperature is then lowered to 
55°C to allow for the annealing step. During annealing, primers hybridize to complementary 
sequences flanking the 3’ end of the target sequence. The temperature is then raised to 72°C, 
which allows for optimal Taq polymerase activity during the extension step. Taq polymerase 
attaches dNTPs to the annealed primers, forming a copy of the DNA target gene. These three 
steps make up one cycle of a PCR reaction (Figure 3.8). This cycle is repeated 30 to 40 times to 
achieve acceptable amplification (Arya, Shergill et al. 2005).  
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Figure 3.8: The steps of one PCR cycle leading up to DNA amplification (prepared by author). 
 
Conventional PCR allows for the exponential amplification of the DNA target sequence but it 
does not have the ability to quantify PCR amplicons. Quantitative PCR (qPCR) overcomes this 
problem, as it is able to measure the PCR amplicons generated during each cycle of the PCR 
process (Pestana, Belak et al. 2010). Amplicons are detected using the DNA-intercalating dye, 
SYBR® Green 1, which fluoresces intensely when it binds to the minor groves of double stranded 
DNA. The intensity of the florescence emitted is therefore directly proportional to the double 
stranded DNA present (Arya, Shergill et al. 2005).  
Along with the gene of interest, samples are analysed for expression of a house keeping gene, and 
the amount of target DNA is reported relative to the amount of the house keeping gene for each 
sample. Housekeeping genes are usually expressed at constant levels among different tissues at 
all stages of development and their expression levels should remain relatively constant amongst 
samples (Arya, Shergill et al. 2005). This provides a control by which the quantity of the amplified 
target gene can be measured. Gene expression is analysed by comparing the target gene with the 
house-keeping gene using the Livak and Schmittgen method of quantitation reported as fold 





3.10.2. Protocol  
A) Ribonucleic acid isolation 
Once treatment was removed, cells were incubated with 500µl of Qiazol (Qiagen, Hilden, 
Germany) and 500µl of 0.1M PBS (5min, RT). Cells were mechanically lysed transferred into 
eppendorfs and stored overnight in Qiazol (-80°C). Chloroform (100µl) was added to thawed 
samples and centrifuged (2 000xg, 15min, 4°C). Isopropanol (250µl) was added to the collected 
supernatant and samples were left overnight (-80°C). Thawed samples were centrifuged                 
(12 000xg, 20min, 4°C), the supernatant was removed and the pellet was washed with 500µl of 
ethanol (75%). Thereafter, samples were centrifuged (7 400xg, 15min, 4°C) and the pellet was 
allowed to air dry (10min). The RNA pellet was resuspended in nuclease free water (15µl) and 
placed on ice. The RNA was quantified using the Nanodrop2000 spectrophotometer and the 
A260/A280 ratio was used to assess the RNA integrity. The concentration of RNA was 
standardised to 1 000ng/μl and used to prepare cDNA.  
B) Complementary deoxyribonucleic acid synthesis 
Standardised RNA was used to synthesize cDNA using the iScript cDNA synthesis Kit (Bio-Rad) 
as per manufacturer’s instructions. A reaction mix containing: 5x iScript reaction (2µl), iScript 
reverse transcriptase (0.5µl), nuclease free water (1µl) and standardized RNA template (1µl), was 
prepared for each sample. The samples were then incubated in a thermocycler (GeneAmp® PCR 
System 9700, Applied Biosciences) for 40min (5min at 25˚C, 30min at 42˚C and 5min at 85˚C).  
C) Quantitative Polymerase Chain Reaction 
Gene expression was analysed using the ssoAdvanced™ Universal SYBR® Green Supermix kit 
(Bio-Rad), according to the manufacturer’s instructions. The mRNA expressions of OGG1, CAT, 
SOD2, GPx, c-myc and Tfam were investigated using specific forward and reverse primers (Table 
3.3). GAPDH was used as a house-keeping gene. Reaction volumes consisting of the following 
were prepared: SYBR green (5µl), forward primer (1µl), reverse primer (1µl) and nuclease free 
water (2µl) and cDNA template (1µl). All reactions were carried out in triplicate.  
The samples were amplified using a CFX96 Touch™ Real-Time PCR Detection System (Bio-
Rad). The initial denaturation occurred at 95°C (4min), followed by 37 cycles of denaturation 
[95°C, 15 second (sec)]; annealing (40sec; Temperatures – Table 3.3) and extension (72°C, 30 
sec) followed by a plate read. The method described by Livak and Schmittgen was employed to 
determine the changes in relative mRNA expression, where 2-ΔΔCt represents the fold change 
observed in mRNA expression (Livak and Schmittgen 2001). The expression of the gene of 
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interest was normalised against the house-keeping gene, GAPDH, which was amplified 
simultaneously under the same conditions. 
 








    
 

























3.11. JC-1 - Mitochondrial Membrane Potential Assay 
3.11.1Principle 
Mitochondrial membrane potential (∆ᴪm) is an indicator of cellular health. The ETC maintains 
the membrane potential of the mitochondria therefore any changes to the ETC alters ∆ᴪm. 
Cationic fluorescent dyes such as the JC-1, Rhodamine and Tetramethylrhodamine methyl ester; 
are able to penetrate the mitochondria and can be used to measure ∆ᴪm. These cations have an 
affinity for the negative potential across the inner mitochondrial membrane and are able to 
accumulate within the mitochondria. Therefore, the more negative the ∆ᴪm, the more cationic 
dye will accumulate within the mitochondria, emitting fluorescence which can be quantified. In 
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this study the JC-1 dye was used as it has been reported to be the most reliable indicator of ∆ᴪm 
(Perry, Norman et al. 2011). 
3.11.2. Protocol  
Control and treated cells (50 000 cells per treatment) were incubated in 200µl of 5µg/ml JC-1 
stain (BD Biosciences, San Jose, NJ, USA) (20min, 37°C). The stain was removed via 
centrifugation (400xg, 10min, 24°C) and the cells were washed twice using JC-1 staining buffer. 
Cells were resuspended in 400µl of JC-1 staining buffer and seeded in an opaque 96 well plate in 
triplicate (100µl/well). A blank containing only JC-1 staining buffer was plated in triplicate as 
well (100µl/well). Fluorescence was quantified on a ModulusTM microplate reader (Turner 
Biosystems, Sunnyvale, CA). JC-1 monomers was measured using a blue filter with an excitation 
wavelength of 488nm and emission wavelength of 529nm, while JC-1 aggregates were measured 
using a green filter with an excitation wavelength of 524nm and emission wavelength of 594nm. 
Mitochondrial membrane potential was calculated using equation 3.3. 
 
Equation 3.3: Calculation used to determine mitochondrial membrane potential 
 
3.12. Statistical analysis 
Microsoft Excel 2013 and GraphPad Prism version 5.0 (GraphPad Software Inc., California) were 
used to perform all statistical analyses. The unpaired t-test was used for all assays. All results 
were represented as the mean ± standard deviation unless otherwise stated. A value of p<0.05 was 





CHAPTER 4 – RESULTS 
4.1. Assessment of oxidative stress 
Oxidative stress was evaluated by measuring changes in intracellular ROS, lipid peroxidation, 
protein carbonylation and OGG1 transcript expression levels. 
4.1.1. Analysis of intracellular reactive oxygen species 
Intracellular ROS levels following FB1 exposure was assessed using the H2DCF-DA assay. There 
was a significant increase in intracellular ROS generated by FB1 (116200±9020 RFU) exposure 
when compared to control cells (34740±5739 RFU) (Figure 4.1). 
 








4.1.2. Lipid peroxidation 
Lipid peroxidation was measured by quantifying its by-product – MDA. Higher levels of MDA 
were observed in FB1 treated cells in relation to control cells (Control: 0.1517±0.01443µM vs 
FB1: 0.1857±0.006506µM) (Figure 4.2).  
 
 










4.1.3. Protein carbonylation 
The protein carbonyl assay assessed ROS-induced damage to proteins by quantifying the 
concentration of protein carbonyls. Cellular protein carbonyls formed after FB1 exposure were 




Figure 4.3: FB1 induced oxidative stress in HepG2 cells as evidenced by the significant increase 









4.1.4. DNA oxidation 
The mRNA expression of the oxidative DNA base excision enzyme, OGG1 was used as an 
indirect measurement of DNA oxidation.  The expression of OGG1 was negatively regulated in 
FB1-treated cells (0.2976±0.1115 fold) in contrast to control cells (1.000±5.528×10-7 fold) 
(Figure 4.4).  
 
 









4.2. The anti-oxidant response 
4.2.1. Anti-oxidant regulation 
Elevated ROS generated by FB1 altered the AO status in HepG2 cells. The master regulator of 
endogenous AO is the transcription factor, Nrf2. As seen in figure 4.5, the protein expression of 
total Nrf2 was reduced in FB1 treated cells (Control: 0.3711±0.1001 RBD vs FB1: 
0.2455±0.03701 RBD; Figure 4.5A). 
High concentrations of ROS result in phosphorylation of Nrf2, which marks Nrf2 for nuclear 
translocation. Phosphorylated Nrf2 (pNrf2) protein expression was significantly elevated by FB1 
(Control: 7.241±0.8566 RBD vs FB: 13.71±3.331 RBD; Figure 4.5B). 
 
 
Figure 4.5: There was a decrease in total Nrf2 expression (A: p=0.1111) after FB1 exposure, 
however pNrf2 expression was significantly increased (B: *p=0.0311). 
The protein and mRNA expression of AO genes and proteins regulated by Nrf2 were subsequently 






4.2.2. Superoxide detoxification 
Figure 4.6 shows that a 4.485 fold increase in the protein expression of mitochondrial AO, SOD2 
(Control: 0.9237±0.08307 RBD vs FB1: 4.479±0.8482 RBD). To validate the increased 
expression of SOD2 at the protein level, SOD2 mRNA expression was investigated with qPCR. 
These results revealed that there was a 1.759 fold increase in SOD2 mRNA expression (Control: 
1.000±6.075×10-6 fold vs FB1: 1.759±0.3353 fold). 
 
 
Figure 4.6: SOD2 protein expression was positively regulated (A: **p= 0.0043) with an 










4.2.3. Detoxification of peroxides 
A) Catalase  
In comparison to control cells (0.2717±0.09224 RBD), CAT protein expression was significantly 
higher in FB1 treated cells (0.4918±0.1275 RBD). This was further confirmed by a significant 
increase in CAT mRNA expression after FB1 exposure (Control: 1.000± 6.095×10-7 fold vs FB1: 
1.522±0.1651 fold). In spite of the elevated expression of CAT (Figure 4.7A and B), the activity 
of CAT (Figure 4.7C) was significantly lower in cells incubated with FB1 (58.83±3.175%) in 
comparison to controls cells (71.81±1.570%). 
 
 
Figure 4.7: FB1 enhanced the CAT protein (A: p= 0.0725) and CAT mRNA levels (B:**p= 





B) Glutathione peroxidase and glutathione 
The qPCR results for GPx (Figure 4.8 A) showed a significant up-regulation in FB1 treated cells 
(1.895±0.06500 fold) in contrast to control cells (1.000±6.095×10-6 fold). The concentration of 
GSH (Figure 4.8 B), a co-factor for GPx, was 2.27 folds greater in FB1 treated cells (Control: 
7.712±1.136 µM vs FB1: 17.51±3.753 µM). 
 
 
Figure 4.8: The transcript levels of the enzyme GPx (A: ***p= 0.0001) and the associated AO, 











4.3. Mitochondrial stress response 
Mitochondrial membrane potential (∆mᴪ) is an indicator of mitochondrial health. The JC-1 assay 
was used to determine mᴪ and found that it was slightly reduced in FB1 treated cells (Control: 


















Mitochondrial DNA (mtDNA) is extremely susceptible to oxidative damage due to the close 
proximity to the ETC. Mitochondrial DNA is stabilized by the transcription factor, Tfam. 
Transcript levels of Tfam were significantly increased by FB1 stimulation (Control:  


















Mitochondrial stress response proteins, Sirt 3 and Lon-P1 are highly expressed during oxidative 
and mitochondrial stress. Western blot analysis of Sirt 3 revealed a 2.03 fold increase in FB1 
treated cells (Control: 3.756±0.5772 RBD vs FB1: 7.630±0.003007 RBD; Figure 4.11A). The 
protein expression of the protease, Lon-P1 (Figure 4.11 B) was also significantly higher in cells 
exposed to FB1 (0.3243±0.01713 RBD) when compared to control cells (0.1885±0.01222 RBD). 
 
 
Figure 4.11: Mitochondrial stress response was heightened after FB1 exposure; Sirt 3 (A: ***p= 










4.4. Expression of cancer-related genes 
The expression of specific oncogenes and tumour suppressor genes are regulated by excessive 
intracellular ROS that may trigger the onset of cancer. Western blotting and qPCR was used to 
determine the expression of these proteins/genes in HepG2 cells. 
4.4.1. c-Myc expression 
The oncogenic c-Myc is an early response gene that is responsible for many of the changes that 
occur in normal cells that induces malignancy. Fumonisin B1 (1.564±0.08688 fold) upregulated 
c-Myc gene expression relative to the untreated control (1.000±6.095×10-6  fold) (Figure 4.12B). 
However, the protein expression of c-Myc was reduced (Control: 1.560 ± 0.5135 RBD vs FB1: 
1.193 ± 0.2505 RBD) (Figure 4.12A). 
 
 
Figure 4.12: Analysis of c-Myc protein expression revealed that there was a decrease (A:p= 
0.4594) however c-Myc transcript levels were significantly increased (B:***p= 0.0004) after 






4.4.2. p53 expression 
The tumour suppressor p53 is one of the most frequently altered genes in human cancers. Elevated 
levels of ROS generated after FB1 exposure induced significant phosphorylation of serine 20 of 
p53 (Figure 4.13A; Control: 1.765 ± 0.3261 RBD vs FB1: 7.346 ± 0.2069 RBD) yet the expression 
of total p53 was reduced after incubation with FB1 (Figure 4.13B; Control: 0.4381 ± 0.07887 
RBD vs FB1: 0.2306 ± 0.1091 RBD). 
 
 
Figure 4.13: The protein expression of phosphorylated p-ser20-p53 was significantly in 










Chapter 5 – Discussion 
The mycotoxin, FB1, is a world-wide contaminant of maize and maize-based products. It is 
nephrotoxic, cytotoxic and hepatotoxic to both animals and humans (WHO 2001). Although FB1 
is poorly absorbed in humans, a major portion of absorbed FB1 is distributed to the liver (Voss, 
Howard et al. 2002). The liver is the oxidative hub for many metabolic and detoxification 
reactions. Hepatocytes have a high density of mitochondria, putting it at great risk to oxidative 
insult (Degli Esposti, Hamelin et al. 2012). 
The primary function of the mitochondria is to generate ATP via the ETC. Normal mitochondrial 
metabolism contributes to the generation of ROS, by leaking unpaired e-s into the mitochondrial 
matrix. These e-s react with molecular O2 forming O2•-; which is converted to H2O2 and eventually 
to the most damaging form of ROS – OH•-. Unwarranted production of ROS from the ETC can 
be stimulated by a number of factors; one being the inhibition of complex I of the ETC (Bratic, 
Larsson et al.). Domijan and Abramov have reported that FB1 inhibits complex I of the ETC, 
resulting in the enhanced generation of ROS and mitochondrial depolarisation; which further 
contributes to the oxidative environment (Domijan and Abramov 2011). Hence, inhibition of 
complex I of the ETC may explain the mitochondrial depolarization and increased levels of 
intracellular ROS observed after FB1 exposure in HepG2 cells. Previous studies have also 
reported that FB1 triggered the generation of intracellular ROS in mouse GT1-7 hypothalamic 
cells, rat C6 glioblastoma cells and human U-118MG glioblastoma cells (Stockmann-Juvala, 
Mikkola et al. 2004a, Stockmann-Juvala, Mikkola et al. 2004b). Interestingly, FB1 did not alter 
ROS production in neuroblastoma SH-SY5Y cells as reported by Stockmann-Juvala, et al., 
however Domijan and Abramov observed significantly higher levels of  ROS in SH-SY5Y cells 
after incubation with FB1 (Stockmann-Juvala, Mikkola et al. 2004a, Domijan and Abramov 
2011). 
This study supports previous studies that showed oxidative stress was induced by FB1 exposure. 
One consequence of uncontrolled production of ROS is the peroxidation of lipids (Ayala, Mu et 
al. 2014). The TBARS assay – which quantifies ROS mediated damage to lipids – showed that 
FB1 significantly increased lipid peroxidation in cells. This is supported by findings in a number 
of different studies involving human cell lines and animal in vivo and in vitro models (Kouadio, 
Mobio et al. 2005, Bernabucci, Colavecchia et al. 2011, Wang, Wu et al. 2016) 
Additional downstream repercussions of elevated ROS include nucleic acid and protein oxidation. 
FB1 has been implicated in both these outcomes as evidenced by Mary, Theumer et al., who 
showed a significant increase in the formation of protein carbonyls and mis-incorporation of 8-
oxoG in the DNA of smooth muscle cells after a 48h incubation with FB1 (Mary, Theumer et al. 
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2012). A 24h exposure to FB1 resulted in significant increase in protein oxidation as measured 
using the protein carbonyl assay. Although DNA oxidation was not measured, the mRNA 
expression levels of the DNA base excision repair enzyme – OGG1 was measured. 8-Oxoguanine 
glycosylase is responsible for removing the major oxidative lesion, 8-oxoG from DNA (Ba, 
Aguilera Aguirre et al. 2015). Acute exposure to FB1 downregulated OGG1 transcript levels, and 
by implication would not be able to reduce or inhibit accelerated DNA damage under oxidative 
conditions.  A similar result was observed after a 48h incubation with FB1 in oesophageal cells 
(Khan, Phulukdaree et al. 2017).  Moreover, developing cancer cells maintain low levels of 
OGG1, as 8-oxoG lesions promote genome instability and aides the development of 
carcinogenesis (Nyaga, Lohani et al. 2006, Nakabeppu 2014).  
The induction of the AO defence system is responsible for detoxifying and negating the effects 
of excess ROS within cells. Redox homeostasis relies on the disassociation of the AO 
transcription factor, Nrf2, from Keap-1. Surplus ROS targets Keap-1, altering its conformation; 
which allows Nrf2 to translocate to the nucleus where it binds to the ARE and promotes AO 
transcription (Nguyen, Nioi et al. 2009). The expression of total Nrf2 was only slightly reduced 
post-FB1 exposure, however pNrf2 was significantly elevated. Most transcription factors – 
including Nrf2 – are regulated by phosphorylation. Excess ROS activates phosphorylation 
pathways such as mitogen-activated protein kinase (MAPK) and protein kinase c (PKC), which 
in turn participate in the phosphorylation and activation of the Nrf2-ARE (Chen, Lu et al. 2015). 
Phosphorylation of Nrf2 triggers its disassociation from Keap-1 ubiquitination, allowing it to 
translocate to the nucleus and promote the transcription of AO (Huang, Nguyen et al. 2002). 
Studies have shown that FB1 activates both the MAPK and PKC pathways contributing further to 
Nrf2 phosphorylation (Yeung, Wang et al. 1996, Pinelli, Poux et al. 1999) 
Major AO enzymes regulated by Nrf2 include: SOD2, CAT and GPx. These AO enzymes are the 
first to respond to excessive ROS and therefor serve as redox biomarkers (Wang, Wu et al. 2016). 
Surplus O2•-, produced by dysregulated ETC, are detoxified to H2O2 by SOD2. Hydrogen peroxide 
is further detoxified by CAT and GPx to H2O and O2 (Weir, Lane et al. 2013). The expression of 
SOD2, CAT and GPx were all upregulated in HepG2 cells after exposure to FB1.  The expression 
of these AO, however, were reduced in Balb/c mice and peripheral blood mononuclear cells 
(PBMC) exposed to FB1 (Bernabucci, Colavecchia et al. 2011, Abbes, Ben Salah-Abbes et al. 
2016). Although the protein and mRNA expression of CAT was higher after incubation with FB1; 
its activity was reduced. These results were supported by Domijan and Peraica et al (Domijan, 
Peraica et al. 2007). Reduced activity of CAT results in the poor detoxification of H2O2. If left in 
its native form, H2O2 is converted to OH•-, resulting in further oxidative damage.  
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An alternative mechanism for H2O2 detoxification is modulated by GPx and its co-factor GSH. 
Glutathione is a major intra-cellular AO in hepatocytes that protects against oxidative damage 
and is involved in detoxification of xenobiotics. After a 24h incubation with FB1, GPx mRNA 
and GSH concentration was significantly elevated in HepG2 cells. This is in agreement with 
results obtained by Domijan and Abramov, who showed a significant increase of GSH in SH-
SY5Y cells after a 24h incubation with FB1 (Domijan and Abramov 2011). Long term exposure 
to FB1 however, reduces GSH concentration (Stockmann-Juvala, Mikkola et al. 2004b). Elevation 
of GSH could be a result of the increased availability of GSH’s cofactor, NADPH and components 
required for GSH synthesis. Inhibition of sphingolipid synthesis by FB1 distorts the structure of 
membrane receptors such as the folate receptor (Stevens and Tang 1997). Inhibition of folate 
uptake promotes the conversion of homocysteine to cysteine, a key amino acid required for the 
synthesis of GSH (Stevens and Tang 1997, Lu 2009). Inhibition of sphingolipid synthesis also 
increases the concentration of available NADPH as sphingolipid synthesis requires the oxidation 
of NADPH (Gault, Obeid et al. 2010). 
As discussed previously, ROS produced by ETC results in the depolarization of the mitochondria, 
which may lead to mitochondrial dysfunction. After observing a mild reduction in ∆ᴪm, 
mitochondrial stress responses to FB1 were assessed.   
Considering mtDNA is in close proximity to the ETC, it is highly vulnerable to oxidative damage 
as they lack protective histone packaging (Gao, Laude et al. 2008). In order to deal with oxidative 
insult, mtDNA is organized within a nucleoid. The core components of the nucleoid are regulated 
by the transcription factor Tfam (Gilkerson, Bravo et al. 2013). This transcription factor belongs 
to a family of high mobility group (HMG) proteins that regulate the transcription of genes encoded 
by mtDNA and controls mtDNA copy number. Due to the abundance of Tfam and its ability to 
bind non-specifically to DNA, Tfam protects mtDNA further by binding directly to the whole 
genome (Kanki, Ohgaki et al. 2004). The increased transcript levels of Tfam after exposure to 
FB1 maybe a mechanism that mitochondria employ to protect mtDNA from oxidative damage. 
However, high levels of ROS trigger the phosphorylation of Tfam, preventing it from binding to 
mtDNA. This leaves mtDNA vulnerable to ROS-induced mutations that could alter the bio-
energetic and bio-synthetic state of the mitochondria that favour cancer cell survival. 
Phosphorylation of Tfam is also mediated via cAMP-dependent protein kinase (PKA) and 
extracellular signal-regulated kinases (ERK) cascades (Lu, Lee et al. 2013, Wang, Zhu et al. 
2014). Although phosphorylation of Tfam was not measured in this study, FB1 is a known 
activator of the ERK pathway and is thus involved in Tfam phosphorylation. (Rumora, Domijan 
et al. 2007). This further enhances Tfam phosphorylation, leaving mtDNA vulnerable to ROS and 
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may promoting mutagenesis and genome instability. Phosphorylation of Tfam leads to its rapid 
degradation by the primary mitochondrial protease – Lon-P1. By controlling Tfam degradation, 
Lon-P1 also regulates mtDNA copy number and transcription (Bota and Davies 2016).  
Furthermore, Lon-P1 is responsible for degrading oxidised proteins such as protein carbonyls 
within the mitochondrial matrix (Gibellini, Pinti et al. 2014). Several reports indicate that Lon-P1 
expression and activity increases in the presence of high levels of carbonylated proteins (Pinti, 
Gibellini et al. 2015). The 11.9 fold increase in protein carbonyls by FB1 may have induced the 
upregulation in Lon-P1 expression in HepG2 cells. The clearance of oxidised proteins within the 
mitochondria is essential as oxidised proteins tend to aggregate and crosslink, resulting in 
mitochondrial toxicity (Ugarte, Petropoulos et al. 2010). Thus, the  upregulation of Lon-P1,  
reduces  mitochondrial stress and maintains mitochondrial integrity (Ngo, Pomatto et al. 2013).  
Lon-protease 1 is post-transcriptionally activated by the mitochondrial deactylase enzyme, Sirt 3 
(Bota and Davies 2016).  Sirtuin 3 upregulation by FB1 counteracts the highly oxidative 
environment of the mitochondria. Sirtuin 3 does not have any direct AO capabilities but is able 
to upregulate the mitochondrial AO capacity via two methods. The first method involves 
activating the mitochondrial AO, SOD2, via deacetylation. The second method involves the 
enhancing IDH2 activity through Sirt3-mediated deacetylation. The activity of IDH2 produces 
increased levels of NADPH, which in turn can increase the activity of GR to further facilitate 
regeneration of GSH from GSSG. Together increased SOD2 and IDH activity increases the 
detoxification capacity of the mitochondria (Bause and Haigis 2013). Oxidative damage to 
mtDNA can also be repaired by Sirt 3 through the deacetylation and stabilisation of mitochondrial 
OGG1, and hence reduce mitochondrial stress (Kincaid and Bossy-Wetzel 2013).  
Functional mitochondria are essential for the survival of cancer cells. While high levels of ROS 
within the mitochondrial matrix cause mutations to mtDNA, these mutation do not usually disrupt 
the functioning of mitochondria but rather alter the bio-energetic and bio-synthetic states to ensure 
that the energy and growth requirements of cancer cells are met (Wallace 2012). While high ROS 
levels are beneficial to cancer cells they must be maintained at certain levels to ensure that cell 
death pathways are not initiated (Liou and Storz 2010) Therefore, Tfam, Sirt 3 and Lon-P1 work 
together to maintain mitochondrial integrity. 
A close relationship exists between Nrf2, ROS and the tumour suppressor gene – p53. High levels 
of ROS activates p53 resulting in cell cycle arrest, AO induction and DNA repair. When oxidative 
damage exceeds cellular AO capacity, p53 provokes a pro-oxidant response, which subsequently 
elicits p53-dependant apoptosis (Liu, Chen et al. 2008). High levels of ROS also lead to the 
phosphorylation of serine 20 of p53. Serine 20 lies within the Mouse double minute 2 (MDM-2) 
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binding site of p53. Phosphorylation of p53’s serine 20 disrupts p53 degradation by MDM-2 
thereby activating its growth arrest and apoptotic function (Jabbur, Huang et al. 2000). Although 
intracellular ROS levels and phosphorylated-p53 expression was upregulated, the expression of 
total-p53 was reduced.  Sirtuin 3 suppresses p53 expression and activity thus rescuing cells from 
cell cycle arrest and promoting tumour cell survival (Alhazzazi, Kamarajan et al. 2011).  
At low levels, p53 upregulates the expression of Nrf2 and its downstream targets through p21. 
p21 binds directly to Nrf2 preventing Keap1-mediated degradation of Nrf2 (Chen, Jiang et al. 
2012). This prolonged activation of Nrf2 favours the proliferation of cancer cells by promoting 
the transcription of genes that support glucose flux and generate the building blocks of 
macromolecules; as observed in lung, breast, ovarian and endometrial cancer cells (Jaramillo and 
Zhang 2013). Moreover, Nrf2 establishes resistances to chemotherapeutic drugs by promoting the 
expression drug metabolising enzymes and drug efflux transporters (Bai, Chen et al. 2016). 
Recently the transcriptional activation of oncogenes, such as KRAS, BRAF and c-Myc, have been 
found to increase the transcription and activity of Nrf2, resulting in an increase in cytoprotective 
activity in the cell (Sporn and Liby 2012). Although cancer cells require a high concentration of 
ROS, it must be kept under certain levels that would otherwise initiate cell death (Liou and Storz 
2010). The detoxification capacity of Nrf2 maintains ROS concentration under these levels, 
protecting cancer cells from cell death pathways. Thus, oncogenes may promote tumorigenesis in 
part through Nrf2 (Sporn and Liby 2012). The expression of c-Myc was assessed in this study.    
c-Myc regulates the transcription of genes involved in growth control, cell survival, cell adhesion 
and protein synthesis (Dang, Resar et al. 1999). It is also involved in oxidative damage to DNA 
and is able to mitigate the effects of p53 (Vafa, Wade et al. 2002).  Although FB1 significantly 
increased c-Myc transcript levels, c-Myc protein expression levels were reduced. c-Myc is 
abundantly expressed at the transcript level in a number of cancers including hepatocellular 
carcinoma (Dang, Resar et al. 1999, Koutb, Abdel-Rahman et al. 2017). Overexpression of the c-
Myc protein triggers apoptotic events, therefore inhibition of c-Myc translation may be a 
mechanism to prevent cell death (Hoffman and Liebermann 2008).  
Exposure to FB1 generated oxidative stress within HepG2 cells, inducing mitochondrial and AO 
responses to mitigate the effects of elevated ROS. These responses were compromised to promote 
the development and survival of cancer cells by creating a more favourable intracellular 
environment that promotes the development of carcinogenesis and aids cancer cell survival. 
Further research must still be done on the role ROS and Nrf2 play in regulating other oncogenes 
and tumour suppressor genes. 
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A summary of the effect of FB1 on oxidative stress related responses and its involvement in 
tumorigenesis in HepG2 cells is represented in Figure 5.1. 
 
Figure 5.1: Summarised account of events. FB1 inhibits the ETC, accelerating ROS production. 
Excessive ROS results in the formation of lipid peroxides and protein carbonyls. ROS also 
results in the phosphorylation and translocation of Nrf2 and hence the increased expression of 
SOD2, CAT and GPx. Tfam, Sirt 3 and Lon-P1 expression were also increased. Along with 
SOD2, these proteins reduce mitochondrial stress. With excessive ROS, improved functioning 
of the mitochondria and prolonged activation of Nrf2, FB1 is able to mediate cancer progression 
(prepared by author). 
5.1. Limitations and future studies 
In this study an in vitro liver model was used to assess oxidative stress related responses after FB1 
exposure. In vitro studies allow for more detailed analysis than can be done in in vivo studies, 
however a shortcoming of this model is that cells are removed from their natural environment, 
thereby eliminating interactions and mechanisms that may otherwise be seen in an intact 
organism. In order to improve this study the use of an in vivo mouse model in addition to the 
primary hepatocyte cell model may give a better understanding of how cells respond to FB1 and 
oxidative stress. 
Cells were only exposed to FB1 for 24h in this study. Cells may respond differently to toxins 
under acute, sub-chronic and chronic conditions, therefore it would be interesting to determine 
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the effects of FB1 in the HepG2 cell line after 6h, 48h and 72h exposure periods to simulate acute, 
sub-chronic and chronic exposures respectively. 
The effect of FB1 and ROS were only assessed on the onco-gene, c-Myc, and tumour suppressor 
protein, p53. The effect FB1 has on other oncogenes regulated by ROS such as KRAS and ERK 
should be further investigated. Additionally, Nrf2’s role in FB1-mediated tumorigenesis should 






















CHAPTER 6 – CONCLUSION 
 
This study demonstrated that exposure to FB1 triggers increased ROS production. Although AO 
responses were initiated (upregulated pNrf2, CAT, SOD, GPx and GSH), the anti-oxidant 
capacity was not enough to deal with the excessive ROS generated by the cell as evidenced by 
formation of lipid peroxides and protein carbonyls. Furthermore mitochondrial survival responses 
(upregulated SOD2, Tfam Sirt 3 and Lon-P1) initiated by the cell unintentionally contributed to 
its own downfall by reducing mitochondrial stress and inhibiting the tumour suppressor p53, 
thereby promoting tumorigenesis. Hence the excessive ROS induced by FB1, and compromised 
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Cytochrome P450 3A4 assay 
Cytochrome P450 3A4 (CYP450 3A4) is expressed abundantly in the liver and detoxifies a wide 
variety of xenobiotics. Cytochrome P450 3A4 activity (Figure 6) was significantly increased 
(p=0.0383) from 206.1±9.860 (Relative light units (RLU) in the control cells to 264.4±13.17 RLU 
in cells treated with FB1 and 296.0±16.83 RLU in cells treated with Dexamethasone (DEX- 
positive control). 
 
Figure 6: There was a 1.3 fold increase in the activity of CYP 3A4 in FB1 treated cells 
(*p<0.05).  
CYP450 3A4 activity could be an additional mechanism for oxidative stress in FB1 treated cells. 
CYP450 3A4 is expressed in high levels in the liver, where it catalyses oxidation and 
detoxification of a wide variety of xenobiotics. The metabolism of xenobiotics by CYP450 3A4 
leads to the formation of ES and ROS. The increase in CYP450 3A4 activity in cells treated with 
FB1, indicates that CYP450 3A4 could play a role in FB1 metabolism. ROS generated by CYP450 








Expression of phosphorylated Sirtuin 1 
Sirtuin 1 (Sirt 1) is a cystolic protein that belongs to the same SIR2 family as Sirt 3. Figure 7 
shows that the expression of phosphorylated Sirt 1 was reduced in cells treated with FB1 (Control: 
0.5492±0.03891 RBD vs FB1: 0.1558±0.01843 RBD). 
 
Figure 7: FB1 significantly downregulated the expression of pSirt 1 (***p<0.0001). 
Phosphorylated Sirt 1 has tumour suppressor properties and protects against oxidative stress by 
inducing the expression of CAT. Therefore the significant decrease in Sirt 1 expression may 











Lactate dehydrogenase assay  
Fumonisin B1 induced significant (p=0.0177) cell membrane damage indicating necrosis 
evidenced by increased lactate dehydrogenase (LDH) leakage compared to control (control: 
1.035±0.03602 Optical density vs. FB1: 1.146±0.03424 Optical density) (Figure 8). 
 
Figure 8: FB1 disrupted membrane integrity evidenced by significant LDH leakage (*p=0.0177). 
There was a 1.1 fold increase in LDH leakage in FB1 treatments. 
 
Elevated LDH in the extracellular matrix is an indicator of necrosis. Although p53-dependant 











Calculation of GSH concentration using a standard curve.  
Mean relative light units (RLU) obtained from GSH standards.  
Concentration 
GHS (µM) 




3.125 210051 241158 225604.5 
6.25 889358 10001540 945449 
12.5 1105770 1747520 1426645 
25 2301910 1493460 1897685 
50 2194630 3522770 2858700 
 
 
Figure 9: Standard curve obtained from GSH standards and the equation obtained from it. 
The equation obtained from the GSH standard curve is y = 53378x + 382684; where y = RLU of 
the sample and x = the concentration of GSH of sample. Therefore the equation can be re-
arranged to: 𝑥 =  
𝑦 −382684
53378
. The GSH concentration in µM (x) can be calculated by substituting 





The concentration of RNA extracted from cells was determined using the Nanodrop 2000 
spectrophotometer. Concentration of RNA that was extracted is as follows: 
 Control cells: 13 200.9 ng/µl 
 FB1 exposed cells: 13 877.9 ng/µl. 



















Supplementary qPCR data; which includes the amplification curves and melt peaks for 
each qPCR undertaken are shown below. 
 
Figure 10: Amplification curve (A) and melt peak (B) analysis for OGG1. 
 
 





Figure 12: Amplification curve (A) and melt peak (B) analysis of CAT.  
 
 




Figure 14: Amplification curve (A) and melt peak (B) analysis of Tfam. 
 
 
Figure 15: Amplification curve (A) and melt peak (B) analysis of c-myc. 
